data_2mm5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mm5 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 23.4 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.862 0.363 . . . . 34.24 110.954 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.494 HG11 ' HG ' ' A' ' 29' ' ' CYS . 79.3 t -90.8 136.69 27.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.532 0.682 . . . . 61.3 111.166 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HD2' HG12 ' A' ' 2' ' ' VAL . 53.5 Cg_endo -69.79 -88.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.63 2.22 . . . . 71.31 112.349 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -151.25 148.62 28.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 74.44 110.901 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 67.07 13.38 9.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 73.2 110.885 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.2 114.26 4.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 75.43 112.489 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 7' ' ' VAL . 2.7 p -45.89 104.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.898 0.38 . . . . 61.14 111.112 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 5.0 p -121.8 172.36 8.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 73.31 110.889 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.93 118.74 4.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 63.54 110.931 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.81 174.67 30.93 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 50.22 112.456 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 11' ' ' ILE . 1.0 OUTLIER -109.43 -42.49 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.333 . . . . 71.32 111.108 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.434 ' H ' HG22 ' A' ' 11' ' ' ILE . 65.2 mt -109.92 -57.79 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 72.21 111.122 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -107.52 119.27 38.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 72.13 110.944 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 179.87 -31.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 74.11 110.91 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 33.1 m -126.85 -164.02 1.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 73.14 110.901 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -135.63 131.11 35.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.455 . . . . 74.33 110.872 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.497 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -69.09 160.24 79.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.544 0.688 . . . . 72.14 110.882 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.4 Cg_endo -69.79 -9.84 11.26 Favored 'Cis proline' 0 C--O 1.232 0.213 0 C-N-CA 122.681 -1.8 . . . . 73.41 112.316 0.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.2 163.51 26.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 72.12 110.919 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -173.05 146.45 1.49 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 75.32 110.915 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.584 ' HG ' ' H ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -48.05 145.37 3.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 62.43 110.899 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.665 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 174.95 171.2 0.29 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.733 0.777 . . . . 54.11 110.877 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 1.007 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.9 Cg_endo -69.71 -32.13 4.1 Favored 'Cis proline' 0 C--N 1.342 0.214 0 C-N-CA 122.649 -1.813 . . . . 74.41 112.382 -0.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.007 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 54.4 Cg_endo -69.78 -163.03 0.1 OUTLIER 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.691 2.261 . . . . 73.21 112.346 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -93.21 -38.1 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 60.33 111.111 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.7 m-30 -115.02 82.93 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 74.3 110.9 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.584 ' H ' ' HG ' ' A' ' 21' ' ' CYS . . . -147.9 -121.12 1.2 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.645 -0.788 . . . . 54.54 112.443 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -122.4 151.77 40.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 70.03 110.823 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 13.1 m -75.38 148.41 39.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 73.1 110.875 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.4 mm . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 71.23 111.167 179.907 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.88 0.372 . . . . 74.1 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.479 HG12 ' HD2' ' A' ' 3' ' ' PRO . 85.1 t -102.33 137.11 19.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 75.13 111.178 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.479 ' HD2' HG12 ' A' ' 2' ' ' VAL . 54.5 Cg_endo -69.73 -87.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.718 2.279 . . . . 71.15 112.348 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.418 ' H ' ' HG2' ' A' ' 3' ' ' PRO . 8.1 tt0 -148.68 151.02 34.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 74.25 110.956 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 64.7 28.4 13.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 72.12 110.898 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.413 ' HA3' HG11 ' A' ' 2' ' ' VAL . . . -116.88 119.15 4.38 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.737 -0.744 . . . . 63.35 112.516 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.9 p -49.36 121.5 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.846 0.355 . . . . 62.12 111.1 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 1.1 p -140.15 163.42 32.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 71.52 110.917 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -154.35 111.5 3.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 64.3 110.872 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.649 ' N ' HE21 ' A' ' 14' ' ' GLN . . . 145.95 156.59 6.94 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 73.04 112.514 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.534 HG23 HD11 ' A' ' 25' ' ' ILE . 13.3 pt -111.85 -30.08 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.742 0.306 . . . . 64.34 111.149 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.2 mm -72.28 -34.27 48.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 62.12 111.114 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -176.88 142.42 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 61.31 110.902 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.649 HE21 ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER 174.29 -58.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 75.24 110.853 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 6.4 m -92.36 -166.65 1.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 73.14 110.809 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -135.92 128.96 31.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 64.53 110.938 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.504 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -67.89 160.39 74.12 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.619 0.723 . . . . 62.1 110.813 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 52.7 Cg_endo -69.86 -8.95 10.96 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.725 -1.781 . . . . 71.24 112.312 0.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -71.22 162.65 29.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 72.22 110.953 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -174.49 145.6 0.97 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 70.24 110.909 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.54 ' HG ' ' H ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -45.23 147.23 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 75.41 110.897 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.651 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER 177.56 170.34 0.44 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.713 . . . . 64.33 110.884 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 1.025 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 54.0 Cg_endo -69.7 -32.57 3.83 Favored 'Cis proline' 0 C--O 1.231 0.161 0 C-N-CA 122.664 -1.807 . . . . 74.32 112.365 -0.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.025 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.7 Cg_endo -69.81 -162.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.697 2.264 . . . . 74.01 112.334 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.534 HD11 HG23 ' A' ' 11' ' ' ILE . 1.4 tt -93.13 -40.98 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 73.13 111.171 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.459 ' CE1' HD12 ' A' ' 25' ' ' ILE . 6.4 m-30 -109.56 79.22 1.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 74.31 110.93 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.54 ' H ' ' HG ' ' A' ' 21' ' ' CYS . . . -143.61 -124.77 1.86 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.748 . . . . 61.12 112.488 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -121.14 147.21 45.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.372 . . . . 72.01 110.849 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.739 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 17.9 m -65.54 146.65 54.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 64.54 110.86 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.41 ' HA ' HD12 ' A' ' 30' ' ' ILE . 45.5 mm . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 71.03 111.139 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.86 0.362 . . . . 72.25 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.624 ' CG1' ' HG ' ' A' ' 29' ' ' CYS . 95.9 t -91.06 136.87 26.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.555 0.693 . . . . 72.34 111.171 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.47 ' HD2' HG12 ' A' ' 2' ' ' VAL . 54.4 Cg_endo -69.78 -92.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.668 2.245 . . . . 75.14 112.381 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.475 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 1.8 tt0 -146.47 145.4 30.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 74.05 110.916 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 58.92 25.99 14.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.42 . . . . 72.04 110.898 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -100.67 29.2 12.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 72.42 112.432 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.508 ' O ' HG23 ' A' ' 7' ' ' VAL . 2.4 p 35.49 82.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 65.02 111.155 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.2 p -103.05 170.5 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 72.33 110.844 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.82 114.51 3.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 43.32 110.886 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.36 161.3 10.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 73.02 112.512 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -105.36 -44.51 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 61.05 111.143 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.8 mm -84.1 -64.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 72.22 111.186 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -126.66 127.15 44.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.03 110.859 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -178.39 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 71.04 110.923 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.1 m -120.94 -165.98 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 62.25 110.886 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -136.57 137.74 40.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 61.33 110.932 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.534 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 3.1 p30 -60.15 155.23 46.53 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.556 0.694 . . . . 64.35 110.879 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.534 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.84 -11.77 12.15 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.594 -1.836 . . . . 61.43 112.35 0.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -65.56 169.19 6.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.334 -0.394 . . . . 71.31 110.893 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -172.62 33.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.506 . . . . 75.23 110.913 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER 65.45 135.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 65.04 110.871 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.634 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 174.75 171.7 0.27 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.678 0.752 . . . . 61.13 110.852 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 1.039 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.6 Cg_endo -69.78 -32.91 3.64 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.729 -1.779 . . . . 73.14 112.376 -0.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.039 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.7 Cg_endo -69.76 -161.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.662 2.241 . . . . 74.45 112.323 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.32 -36.62 6.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 53.23 111.108 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.2 m-85 -117.89 77.64 1.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.54 110.93 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.01 -119.18 1.4 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.755 . . . . 52.44 112.448 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -116.34 153.33 32.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.818 0.342 . . . . 70.31 110.805 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.624 ' HG ' ' CG1' ' A' ' 2' ' ' VAL . 76.5 m -73.07 125.98 28.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 73.22 110.873 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.3 mm . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 72.22 111.112 179.939 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.5 p . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.89 0.376 . . . . 40.22 110.944 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.498 HG13 ' HD2' ' A' ' 3' ' ' PRO . 68.0 t -105.69 137.51 19.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.628 0.728 . . . . 74.33 111.134 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.498 ' HD2' HG13 ' A' ' 2' ' ' VAL . 52.6 Cg_endo -69.79 -87.8 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.686 2.257 . . . . 72.21 112.297 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.417 ' H ' ' HG2' ' A' ' 3' ' ' PRO . 5.7 tt0 -150.09 151.01 32.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 64.41 110.913 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 64.74 24.98 12.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 75.53 110.941 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.73 114.91 3.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 62.31 112.51 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 7' ' ' VAL . 3.8 p -47.65 113.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 64.21 111.178 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 1.2 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 2.9 p -133.46 169.26 17.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 72.13 110.947 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -156.2 120.95 4.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.198 -0.455 . . . . 72.34 110.906 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.452 ' N ' HE21 ' A' ' 14' ' ' GLN . . . 154.12 175.65 25.59 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.77 -0.729 . . . . 52.12 112.493 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.459 HG23 ' H ' ' A' ' 12' ' ' ILE . 0.5 OUTLIER -115.1 -46.69 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.84 0.353 . . . . 64.2 111.133 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.459 ' H ' HG23 ' A' ' 11' ' ' ILE . 9.6 mm -84.43 -66.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 61.3 111.078 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -114.17 135.37 54.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 62.53 110.846 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.452 HE21 ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER 179.67 -50.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 65.4 110.898 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 1.2 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 56.6 m -114.92 -162.54 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 71.35 110.898 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.6 OUTLIER -135.22 127.43 30.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 62.1 110.834 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -65.08 160.3 57.9 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.606 0.717 . . . . 75.1 110.885 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.0 Cg_endo -69.85 -9.55 11.25 Favored 'Cis proline' 0 C--O 1.232 0.177 0 C-N-CA 122.606 -1.831 . . . . 51.15 112.321 0.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -70.93 164.03 26.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 74.41 110.953 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -175.51 145.56 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 73.33 110.959 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.55 ' HG ' ' H ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -45.59 145.34 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 52.31 110.898 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.618 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER 179.98 169.78 0.66 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.677 0.751 . . . . 43.13 110.86 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 1.061 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.3 Cg_endo -69.78 -33.41 3.43 Favored 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.73 -1.779 . . . . 74.41 112.297 0.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.061 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.8 Cg_endo -69.78 -162.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.693 2.262 . . . . 50.0 112.341 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 tt -95.3 -34.73 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 71.24 111.144 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.8 m-30 -113.45 79.36 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 74.31 110.951 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.55 ' H ' ' HG ' ' A' ' 21' ' ' CYS . . . -146.49 -124.18 1.56 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 72.32 112.517 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -121.47 148.43 44.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 65.12 110.83 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.73 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 16.5 m -66.45 147.04 53.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 75.4 110.931 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.448 ' HB ' ' HG ' ' A' ' 22' ' ' SER . 47.2 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 73.31 111.094 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.93 0.395 . . . . 75.23 110.824 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.574 ' CG1' ' HG ' ' A' ' 29' ' ' CYS . 97.5 t -98.14 136.34 21.03 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.661 0.743 . . . . 64.54 111.113 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.439 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.8 Cg_endo -69.83 -91.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.619 2.212 . . . . 54.11 112.372 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.439 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 3.3 tt0 -146.54 146.66 30.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.425 . . . . 74.22 110.91 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 57.5 43.42 22.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 65.15 110.849 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -120.57 28.36 6.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.74 . . . . 72.52 112.467 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.503 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 p 35.84 83.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.363 . . . . 53.53 111.102 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 p -102.75 169.86 8.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 51.33 110.923 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -155.01 119.47 4.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 71.34 110.872 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.99 175.29 28.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 73.42 112.492 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.7 tp -109.18 -43.4 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 64.02 111.164 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.1 mt -109.97 -57.78 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 74.23 111.134 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -106.16 122.83 47.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 75.24 110.873 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 176.76 -46.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.151 -0.477 . . . . 73.44 110.939 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 20' ' ' TYR . 69.7 m -113.06 -162.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 71.25 110.894 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.413 ' H ' ' HB3' ' A' ' 15' ' ' CYS . 0.8 OUTLIER -135.09 137.23 42.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 64.31 110.974 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.554 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 10.3 m-20 -59.21 150.79 61.28 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 64.15 110.793 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.554 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.68 -22.96 9.26 Favored 'Cis proline' 0 C--N 1.342 0.235 0 C-N-CA 122.678 -1.801 . . . . 75.02 112.348 -0.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -51.35 163.59 0.25 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 73.33 110.968 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.414 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -171.39 30.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.5 . . . . 72.45 110.894 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.542 ' HG ' ' H ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER 64.59 143.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 61.44 110.866 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.621 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 173.75 171.81 0.25 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.694 0.759 . . . . 71.44 110.836 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 1.065 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.9 Cg_endo -69.76 -33.53 3.38 Favored 'Cis proline' 0 C--O 1.231 0.164 0 C-N-CA 122.684 -1.798 . . . . 43.32 112.322 0.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.065 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 54.3 Cg_endo -69.67 -162.11 0.09 OUTLIER 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.674 2.25 . . . . 64.54 112.382 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.1 -36.81 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 71.02 111.098 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.5 m-30 -115.76 79.3 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.874 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.542 ' H ' ' HG ' ' A' ' 21' ' ' CYS . . . -143.22 -120.9 1.55 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.779 -0.724 . . . . 61.32 112.504 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 40.6 m-70 -117.4 150.39 38.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.863 0.363 . . . . 71.23 110.845 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.574 ' HG ' ' CG1' ' A' ' 2' ' ' VAL . 70.9 m -70.14 126.74 30.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 74.45 110.924 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.5 mm . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.13 -0.486 . . . . 73.55 111.122 179.978 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 1.283 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.953 0.406 . . . . 63.22 110.827 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.514 HG13 ' HD2' ' A' ' 3' ' ' PRO . 43.9 t -148.73 136.96 11.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.6 0.714 . . . . 53.42 111.125 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.514 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.4 Cg_endo -69.65 -91.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.716 2.277 . . . . 54.22 112.377 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 6.2 tt0 -145.38 147.45 32.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 71.1 110.932 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 57.01 44.68 22.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 74.24 110.916 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -113.72 23.51 13.2 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 73.13 112.447 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.469 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.3 p 35.62 85.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.83 0.348 . . . . 54.55 111.113 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.3 p -113.71 172.98 6.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 73.31 110.923 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -158.38 118.83 3.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 75.43 110.831 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.01 158.12 7.59 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.755 -0.736 . . . . 64.41 112.515 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.527 HG23 HD11 ' A' ' 25' ' ' ILE . 1.6 pp -109.64 -27.56 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 72.21 111.144 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.3 mt -89.33 -35.37 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 73.21 111.168 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -163.08 133.39 4.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 71.13 110.889 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.622 ' HG2' ' HG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -178.7 -31.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.474 . . . . 71.13 110.899 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.622 ' HG ' ' HG2' ' A' ' 14' ' ' GLN . 96.9 m -136.78 -166.73 1.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 73.51 110.926 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 1.283 ' SG ' ' SG ' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -130.46 149.57 52.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 72.34 110.919 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.532 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 1.7 p30 -66.52 156.31 86.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.65 0.738 . . . . 62.43 110.861 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.3 Cg_endo -69.78 -14.49 12.53 Favored 'Cis proline' 0 C--N 1.342 0.214 0 C-N-CA 122.694 -1.794 . . . . 71.24 112.375 0.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -63.74 170.19 3.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 74.3 110.915 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.78 35.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.878 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER 65.35 138.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 70.43 110.89 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.66 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 174.42 172.7 0.25 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.627 0.727 . . . . 72.3 110.867 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 1.011 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.8 Cg_endo -69.76 -32.29 4.02 Favored 'Cis proline' 0 C--N 1.341 0.176 0 C-N-CA 122.674 -1.803 . . . . 65.04 112.366 0.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.011 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.0 Cg_endo -69.82 -164.09 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.672 2.248 . . . . 71.43 112.359 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.56 HD12 ' CE1' ' A' ' 26' ' ' TYR . 4.0 tt -90.02 -38.89 11.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 74.44 111.181 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.56 ' CE1' HD12 ' A' ' 25' ' ' ILE . 14.4 m-30 -119.05 87.71 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 74.35 110.9 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.412 ' H ' ' HG ' ' A' ' 21' ' ' CYS . . . -151.73 -123.45 1.06 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.784 -0.722 . . . . 32.41 112.488 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.91 149.66 27.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 62.35 110.878 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 85.9 m -72.05 120.29 17.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 43.51 110.795 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.0 mm . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 74.42 111.088 179.891 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.851 0.358 . . . . 75.05 110.814 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.559 ' CG1' ' HG ' ' A' ' 29' ' ' CYS . 90.6 t -95.07 136.79 22.46 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.641 0.734 . . . . 72.43 111.18 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.459 ' HD2' HG12 ' A' ' 2' ' ' VAL . 53.7 Cg_endo -69.72 -92.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.712 2.275 . . . . 64.32 112.371 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.448 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 3.6 tt0 -146.4 146.74 30.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 54.15 110.889 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 58.48 41.28 22.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 74.24 110.943 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -117.56 27.99 7.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 61.01 112.46 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.505 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 p 35.7 82.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.946 0.403 . . . . 64.44 111.138 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.7 p -103.25 168.6 9.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 61.34 110.895 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.15 119.4 4.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 62.11 110.771 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.63 166.13 13.99 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.797 -0.716 . . . . 73.04 112.529 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.404 HG23 ' H ' ' A' ' 12' ' ' ILE . 0.5 OUTLIER -107.19 -44.44 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.728 0.299 . . . . 72.24 111.121 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.407 ' HA ' HD12 ' A' ' 12' ' ' ILE . 9.6 mm -85.29 -65.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 53.05 111.112 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -122.86 131.46 53.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 62.13 110.876 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.35 -25.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 64.53 110.966 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 20' ' ' TYR . 58.6 m -133.13 -164.25 1.45 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 65.21 110.894 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -137.23 139.99 41.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.463 . . . . 64.35 110.853 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.539 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 4.7 p30 -61.35 154.84 61.18 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.648 0.737 . . . . 74.42 110.78 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 55.2 Cg_endo -69.61 -12.31 11.85 Favored 'Cis proline' 0 C--O 1.232 0.205 0 C-N-CA 122.703 -1.791 . . . . 51.3 112.385 -0.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -65.02 168.42 6.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 72.11 110.888 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.406 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -175.09 34.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 71.31 110.875 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER 64.82 139.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 61.24 110.899 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.617 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 172.4 171.15 0.22 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.623 0.725 . . . . 73.35 110.895 -179.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 1.059 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 54.0 Cg_endo -69.78 -33.47 3.41 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.621 -1.824 . . . . 73.45 112.379 0.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.059 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.7 Cg_endo -69.75 -161.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.655 2.237 . . . . 71.34 112.33 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -96.17 -37.44 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 54.21 111.103 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.4 m-30 -116.24 77.51 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 73.43 110.915 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.18 -119.74 1.51 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 51.44 112.488 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -116.72 153.32 32.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 73.45 110.81 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.559 ' HG ' ' CG1' ' A' ' 2' ' ' VAL . 74.6 m -71.64 126.06 28.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 75.22 110.934 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 mm . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 72.43 111.171 179.931 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.916 0.389 . . . . 62.11 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.615 ' CG1' ' HG ' ' A' ' 29' ' ' CYS . 97.8 t -99.14 136.69 20.45 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.628 0.728 . . . . 75.35 111.131 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.458 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.0 Cg_endo -69.8 -92.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.627 2.218 . . . . 73.13 112.31 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.481 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 3.3 tt0 -146.26 145.84 30.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 75.1 110.942 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 58.02 41.98 23.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 62.43 110.889 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -120.25 29.09 6.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.791 -0.719 . . . . 62.51 112.519 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.508 ' O ' HG23 ' A' ' 7' ' ' VAL . 2.4 p 35.92 82.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.341 . . . . 74.12 111.14 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.4 p -101.64 169.34 8.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 41.12 110.917 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -156.35 119.21 4.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 73.1 110.883 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.26 166.14 17.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.7 -0.762 . . . . 24.41 112.473 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.431 HG23 ' H ' ' A' ' 12' ' ' ILE . 0.6 OUTLIER -112.31 -44.11 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.863 0.363 . . . . 73.35 111.109 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.462 HD13 ' HA ' ' A' ' 12' ' ' ILE . 9.3 mm -91.62 -63.7 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 74.45 111.142 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -120.61 134.23 55.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 73.02 110.882 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.88 -74.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 74.01 110.884 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 20' ' ' TYR . 60.7 m -80.42 -163.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 65.41 110.912 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.409 ' H ' ' HB3' ' A' ' 15' ' ' CYS . 0.8 OUTLIER -135.81 138.45 42.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 65.21 110.916 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.55 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 24.1 m-20 -59.61 152.14 58.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.604 0.716 . . . . 74.21 110.912 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.55 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.68 -19.11 11.29 Favored 'Cis proline' 0 C--N 1.342 0.219 0 C-N-CA 122.62 -1.825 . . . . 60.33 112.392 -0.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -56.44 167.26 0.72 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.443 . . . . 75.14 110.875 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.43 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -172.48 31.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 74.12 110.927 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 64.36 141.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.096 -0.502 . . . . 54.12 110.918 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.623 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 173.72 171.63 0.25 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.727 0.775 . . . . 60.54 110.796 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 1.061 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.1 Cg_endo -69.82 -33.36 3.46 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.669 -1.804 . . . . 73.53 112.364 0.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.061 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.3 Cg_endo -69.73 -162.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.722 2.281 . . . . 73.44 112.293 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.3 -37.34 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.466 . . . . 71.02 111.149 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.5 m-30 -115.88 77.92 1.14 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 71.42 110.921 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.478 ' H ' ' HG ' ' A' ' 21' ' ' CYS . . . -141.97 -120.52 1.61 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.727 -0.749 . . . . 60.54 112.496 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -117.35 151.42 37.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 73.11 110.849 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.615 ' HG ' ' CG1' ' A' ' 2' ' ' VAL . 70.8 m -71.33 126.65 30.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 71.24 110.875 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.7 mm . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 64.32 111.117 179.938 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.2 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.84 0.352 . . . . 63.01 110.874 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.522 ' CG1' ' HG ' ' A' ' 29' ' ' CYS . 86.8 t -95.44 135.73 23.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.58 0.705 . . . . 73.02 111.196 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.415 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.7 Cg_endo -69.76 -91.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.691 2.26 . . . . 73.4 112.353 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.436 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 6.6 tt0 -144.65 147.11 32.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 74.33 110.856 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 57.7 43.33 22.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 72.24 110.965 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -120.17 27.83 6.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 65.31 112.513 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 7' ' ' VAL . 2.3 p 35.68 85.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.922 0.391 . . . . 75.3 111.17 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.7 p -105.98 172.93 6.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 71.53 110.857 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -161.37 120.05 2.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 75.41 110.834 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.68 157.72 8.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.681 -0.771 . . . . 24.14 112.494 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.439 HG21 HG13 ' A' ' 25' ' ' ILE . 6.6 pt -114.7 -28.51 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.812 0.339 . . . . 74.42 111.152 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 12' ' ' ILE . 13.0 mm -75.39 -34.91 31.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 74.32 111.157 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -175.18 135.25 0.34 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 52.13 110.889 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.422 ' NE2' ' H ' ' A' ' 15' ' ' CYS . 0.1 OUTLIER 176.54 -61.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 71.42 110.962 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.422 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 92.8 m -90.64 -165.64 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 74.44 110.841 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.56 137.35 40.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 75.2 110.874 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.544 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 5.3 m-20 -58.77 149.86 61.68 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.667 0.746 . . . . 71.24 110.854 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.544 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.73 -23.36 9.09 Favored 'Cis proline' 0 C--N 1.342 0.196 0 C-N-CA 122.714 -1.786 . . . . 71.02 112.284 -0.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -50.42 160.65 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 74.15 110.938 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.5 32.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 71.24 110.937 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.566 ' HG ' ' H ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER 65.08 143.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 74.23 110.862 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.638 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 173.8 170.65 0.26 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.683 0.754 . . . . 60.1 110.829 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 1.048 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 54.2 Cg_endo -69.69 -33.02 3.55 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.748 -1.772 . . . . 61.25 112.364 -0.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.048 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.9 Cg_endo -69.81 -161.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.623 2.215 . . . . 71.45 112.402 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.439 HG13 HG21 ' A' ' 11' ' ' ILE . 1.5 tt -97.23 -35.81 5.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 75.21 111.117 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -116.19 76.74 1.04 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 71.22 110.919 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.566 ' H ' ' HG ' ' A' ' 21' ' ' CYS . . . -141.77 -120.58 1.63 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 62.14 112.48 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.436 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 43.8 m-70 -116.9 149.76 39.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.331 . . . . 63.52 110.914 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 77.1 m -68.71 128.18 35.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 62.22 110.842 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.3 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.493 . . . . 72.11 111.154 179.931 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.934 0.397 . . . . 65.45 110.795 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.581 HG11 ' HG ' ' A' ' 29' ' ' CYS . 96.4 t -90.98 136.87 27.01 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 75.41 111.138 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.46 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.0 Cg_endo -69.71 -91.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.693 2.262 . . . . 65.14 112.374 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -147.12 154.62 41.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 54.15 110.912 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 64.37 14.9 9.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 71.52 110.938 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.7 114.57 4.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 64.4 112.465 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 7' ' ' VAL . 2.7 p -43.36 105.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.839 0.352 . . . . 65.44 111.197 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.0 p -123.32 167.9 13.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 52.23 110.84 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -159.63 108.86 1.83 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.102 -0.499 . . . . 73.34 110.897 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.9 159.15 9.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.66 -0.781 . . . . 72.44 112.416 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -101.66 -43.54 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.774 0.321 . . . . 70.5 111.114 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 12' ' ' ILE . 7.6 mm -84.01 -62.92 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 71.51 111.142 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -123.79 123.67 40.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 71.54 110.945 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -177.88 -33.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 74.13 110.883 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.429 ' HB3' ' H ' ' A' ' 16' ' ' CYS . 79.6 m -129.87 -162.15 1.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 73.12 110.974 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.429 ' H ' ' HB3' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -135.83 135.84 40.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 71.13 110.946 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.537 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 90.2 m-20 -59.36 154.76 40.86 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.617 0.723 . . . . 63.41 110.8 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.537 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.8 -16.0 12.39 Favored 'Cis proline' 0 C--N 1.342 0.188 0 C-N-CA 122.679 -1.8 . . . . 73.52 112.368 0.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -59.01 169.05 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 73.52 110.921 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.26 38.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 74.03 110.966 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 64.17 147.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 63.22 110.853 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.68 ' CB ' ' HA ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER 174.75 175.65 0.22 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.617 0.723 . . . . 53.32 110.843 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.941 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.2 Cg_endo -69.82 -31.64 4.44 Favored 'Cis proline' 0 C--O 1.232 0.204 0 C-N-CA 122.675 -1.802 . . . . 53.41 112.327 -0.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.941 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.5 Cg_endo -69.76 -92.02 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.688 2.259 . . . . 64.32 112.346 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -168.81 -34.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 73.44 111.122 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.4 m-30 -109.93 66.51 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 64.11 110.962 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.64 -110.55 0.64 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.826 -0.702 . . . . 63.25 112.559 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -111.93 149.35 32.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 70.45 110.865 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.581 ' HG ' HG11 ' A' ' 2' ' ' VAL . 90.8 m -72.97 120.8 19.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 73.03 110.889 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.9 mm . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 73.34 111.097 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 1.302 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.89 0.376 . . . . 75.31 110.845 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.464 HG12 ' HD2' ' A' ' 3' ' ' PRO . 57.5 t -150.71 136.02 10.25 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 53.1 111.173 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.464 ' HD2' HG12 ' A' ' 2' ' ' VAL . 54.6 Cg_endo -69.68 -92.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.746 2.297 . . . . 44.44 112.406 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -148.38 149.54 31.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 64.25 110.881 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 59.48 25.97 14.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 75.52 110.911 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -100.1 22.34 40.6 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.68 -0.771 . . . . 70.23 112.564 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.481 ' O ' HG23 ' A' ' 7' ' ' VAL . 2.3 p 35.92 85.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 44.31 111.102 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.6 p -109.51 169.06 8.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 62.34 110.875 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -153.34 117.77 4.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 72.33 110.838 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.32 156.75 7.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.709 -0.757 . . . . 64.23 112.425 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -98.64 -42.41 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 75.21 111.127 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.47 ' HA ' HD13 ' A' ' 12' ' ' ILE . 7.8 mm -89.01 -62.84 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.31 111.211 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -120.1 127.58 52.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 74.43 110.84 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.489 ' HG2' ' HG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -176.25 -34.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 75.03 110.944 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.489 ' HG ' ' HG2' ' A' ' 14' ' ' GLN . 97.7 m -133.96 -167.06 1.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 71.12 110.899 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 1.302 ' SG ' ' SG ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -132.99 157.79 44.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 75.2 110.867 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.523 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -72.2 156.82 90.25 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.609 0.719 . . . . 64.52 110.863 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.7 -12.56 12.11 Favored 'Cis proline' 0 C--N 1.341 0.182 0 C-N-CA 122.718 -1.784 . . . . 64.01 112.343 -0.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -66.0 176.58 1.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 75.52 110.871 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.97 36.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 70.11 110.857 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 65.14 136.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.468 . . . . 74.04 110.872 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.624 ' CB ' ' HA ' ' A' ' 23' ' ' PRO . 0.5 OUTLIER 169.73 173.29 0.13 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.672 0.749 . . . . 71.12 110.846 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 1.029 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.0 Cg_endo -69.76 -33.14 3.52 Favored 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.715 -1.785 . . . . 62.13 112.337 -0.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 1.029 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 54.1 Cg_endo -69.74 -161.46 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.641 2.227 . . . . 53.52 112.435 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.07 -33.65 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.306 -0.406 . . . . 55.13 111.161 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.2 m-85 -122.42 68.44 0.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 72.32 110.922 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -138.81 -117.79 1.54 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.792 -0.718 . . . . 55.13 112.533 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.472 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 54.2 m-70 -104.2 -177.05 3.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 63.14 110.863 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 98.4 m -107.66 121.48 44.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 73.32 110.897 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.6 mm . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 73.15 111.088 179.942 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 23.4 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.862 0.363 . . . . 34.24 110.954 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.494 HG11 ' HG ' ' A' ' 29' ' ' CYS . 79.3 t -90.8 136.69 27.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.532 0.682 . . . . 61.3 111.166 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HD2' HG12 ' A' ' 2' ' ' VAL . 53.5 Cg_endo -69.79 -88.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.63 2.22 . . . . 71.31 112.349 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -151.25 148.62 28.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 74.44 110.901 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 67.07 13.38 9.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 73.2 110.885 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.2 114.26 4.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 75.43 112.489 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 7' ' ' VAL . 2.7 p -45.89 104.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.898 0.38 . . . . 61.14 111.112 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 5.0 p -121.8 172.36 8.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 73.31 110.889 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.93 118.74 4.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 63.54 110.931 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.81 174.67 30.93 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 50.22 112.456 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 11' ' ' ILE . 1.0 OUTLIER -109.43 -42.49 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.333 . . . . 71.32 111.108 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.434 ' H ' HG22 ' A' ' 11' ' ' ILE . 65.2 mt -109.92 -57.79 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 72.21 111.122 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -107.52 119.27 38.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 72.13 110.944 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 179.87 -31.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 74.11 110.91 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 33.1 m -126.85 -164.02 1.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 73.14 110.901 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -135.63 131.11 35.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.455 . . . . 74.33 110.872 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.497 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -69.09 160.24 79.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.544 0.688 . . . . 72.14 110.882 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.4 Cg_endo -69.79 -9.84 11.26 Favored 'Cis proline' 0 C--O 1.232 0.213 0 C-N-CA 122.681 -1.8 . . . . 73.41 112.316 0.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.2 163.51 26.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 72.12 110.919 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -173.05 146.45 1.49 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 75.32 110.915 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.584 ' HG ' ' H ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -48.05 145.37 3.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 62.43 110.899 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.665 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 174.95 171.2 0.29 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.733 0.777 . . . . 54.11 110.877 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 1.007 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.9 Cg_endo -69.71 -32.13 4.1 Favored 'Cis proline' 0 C--N 1.342 0.214 0 C-N-CA 122.649 -1.813 . . . . 74.41 112.382 -0.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.007 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 54.4 Cg_endo -69.78 -163.03 0.1 OUTLIER 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.691 2.261 . . . . 73.21 112.346 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -93.21 -38.1 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 60.33 111.111 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.7 m-30 -115.02 82.93 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 74.3 110.9 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.584 ' H ' ' HG ' ' A' ' 21' ' ' CYS . . . -147.9 -121.12 1.2 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.645 -0.788 . . . . 54.54 112.443 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -122.4 151.77 40.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 70.03 110.823 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 13.1 m -75.38 148.41 39.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 73.1 110.875 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.4 mm . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 71.23 111.167 179.907 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.88 0.372 . . . . 74.1 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.479 HG12 ' HD2' ' A' ' 3' ' ' PRO . 85.1 t -102.33 137.11 19.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 75.13 111.178 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.479 ' HD2' HG12 ' A' ' 2' ' ' VAL . 54.5 Cg_endo -69.73 -87.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.718 2.279 . . . . 71.15 112.348 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.418 ' H ' ' HG2' ' A' ' 3' ' ' PRO . 8.1 tt0 -148.68 151.02 34.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 74.25 110.956 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 64.7 28.4 13.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 72.12 110.898 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.413 ' HA3' HG11 ' A' ' 2' ' ' VAL . . . -116.88 119.15 4.38 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.737 -0.744 . . . . 63.35 112.516 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.9 p -49.36 121.5 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.846 0.355 . . . . 62.12 111.1 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 1.1 p -140.15 163.42 32.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 71.52 110.917 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -154.35 111.5 3.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 64.3 110.872 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.649 ' N ' HE21 ' A' ' 14' ' ' GLN . . . 145.95 156.59 6.94 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 73.04 112.514 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.534 HG23 HD11 ' A' ' 25' ' ' ILE . 13.3 pt -111.85 -30.08 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.742 0.306 . . . . 64.34 111.149 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.2 mm -72.28 -34.27 48.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 62.12 111.114 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -176.88 142.42 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 61.31 110.902 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.649 HE21 ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER 174.29 -58.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 75.24 110.853 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 6.4 m -92.36 -166.65 1.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 73.14 110.809 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -135.92 128.96 31.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 64.53 110.938 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.504 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -67.89 160.39 74.12 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.619 0.723 . . . . 62.1 110.813 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 52.7 Cg_endo -69.86 -8.95 10.96 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.725 -1.781 . . . . 71.24 112.312 0.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -71.22 162.65 29.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 72.22 110.953 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -174.49 145.6 0.97 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 70.24 110.909 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.54 ' HG ' ' H ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -45.23 147.23 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 75.41 110.897 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.651 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER 177.56 170.34 0.44 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.713 . . . . 64.33 110.884 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 1.025 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 54.0 Cg_endo -69.7 -32.57 3.83 Favored 'Cis proline' 0 C--O 1.231 0.161 0 C-N-CA 122.664 -1.807 . . . . 74.32 112.365 -0.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.025 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.7 Cg_endo -69.81 -162.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.697 2.264 . . . . 74.01 112.334 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.534 HD11 HG23 ' A' ' 11' ' ' ILE . 1.4 tt -93.13 -40.98 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 73.13 111.171 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.459 ' CE1' HD12 ' A' ' 25' ' ' ILE . 6.4 m-30 -109.56 79.22 1.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 74.31 110.93 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.54 ' H ' ' HG ' ' A' ' 21' ' ' CYS . . . -143.61 -124.77 1.86 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.748 . . . . 61.12 112.488 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -121.14 147.21 45.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.372 . . . . 72.01 110.849 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.739 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 17.9 m -65.54 146.65 54.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 64.54 110.86 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.41 ' HA ' HD12 ' A' ' 30' ' ' ILE . 45.5 mm . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 71.03 111.139 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.86 0.362 . . . . 72.25 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.624 ' CG1' ' HG ' ' A' ' 29' ' ' CYS . 95.9 t -91.06 136.87 26.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.555 0.693 . . . . 72.34 111.171 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.47 ' HD2' HG12 ' A' ' 2' ' ' VAL . 54.4 Cg_endo -69.78 -92.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.668 2.245 . . . . 75.14 112.381 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.475 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 1.8 tt0 -146.47 145.4 30.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 74.05 110.916 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 58.92 25.99 14.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.42 . . . . 72.04 110.898 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -100.67 29.2 12.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 72.42 112.432 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.508 ' O ' HG23 ' A' ' 7' ' ' VAL . 2.4 p 35.49 82.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 65.02 111.155 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.2 p -103.05 170.5 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 72.33 110.844 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.82 114.51 3.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 43.32 110.886 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.36 161.3 10.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 73.02 112.512 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -105.36 -44.51 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 61.05 111.143 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.8 mm -84.1 -64.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 72.22 111.186 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -126.66 127.15 44.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.03 110.859 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -178.39 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 71.04 110.923 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.1 m -120.94 -165.98 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 62.25 110.886 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -136.57 137.74 40.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 61.33 110.932 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.534 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 3.1 p30 -60.15 155.23 46.53 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.556 0.694 . . . . 64.35 110.879 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.534 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.84 -11.77 12.15 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.594 -1.836 . . . . 61.43 112.35 0.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -65.56 169.19 6.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.334 -0.394 . . . . 71.31 110.893 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -172.62 33.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.506 . . . . 75.23 110.913 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER 65.45 135.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 65.04 110.871 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.634 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 174.75 171.7 0.27 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.678 0.752 . . . . 61.13 110.852 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 1.039 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.6 Cg_endo -69.78 -32.91 3.64 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.729 -1.779 . . . . 73.14 112.376 -0.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.039 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.7 Cg_endo -69.76 -161.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.662 2.241 . . . . 74.45 112.323 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.32 -36.62 6.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 53.23 111.108 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.2 m-85 -117.89 77.64 1.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.54 110.93 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.01 -119.18 1.4 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.755 . . . . 52.44 112.448 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -116.34 153.33 32.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.818 0.342 . . . . 70.31 110.805 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.624 ' HG ' ' CG1' ' A' ' 2' ' ' VAL . 76.5 m -73.07 125.98 28.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 73.22 110.873 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.3 mm . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 72.22 111.112 179.939 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.5 p . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.89 0.376 . . . . 40.22 110.944 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.498 HG13 ' HD2' ' A' ' 3' ' ' PRO . 68.0 t -105.69 137.51 19.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.628 0.728 . . . . 74.33 111.134 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.498 ' HD2' HG13 ' A' ' 2' ' ' VAL . 52.6 Cg_endo -69.79 -87.8 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.686 2.257 . . . . 72.21 112.297 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.417 ' H ' ' HG2' ' A' ' 3' ' ' PRO . 5.7 tt0 -150.09 151.01 32.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 64.41 110.913 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 64.74 24.98 12.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 75.53 110.941 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.73 114.91 3.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 62.31 112.51 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 7' ' ' VAL . 3.8 p -47.65 113.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 64.21 111.178 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 1.2 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 2.9 p -133.46 169.26 17.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 72.13 110.947 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -156.2 120.95 4.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.198 -0.455 . . . . 72.34 110.906 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.452 ' N ' HE21 ' A' ' 14' ' ' GLN . . . 154.12 175.65 25.59 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.77 -0.729 . . . . 52.12 112.493 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.459 HG23 ' H ' ' A' ' 12' ' ' ILE . 0.5 OUTLIER -115.1 -46.69 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.84 0.353 . . . . 64.2 111.133 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.459 ' H ' HG23 ' A' ' 11' ' ' ILE . 9.6 mm -84.43 -66.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 61.3 111.078 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -114.17 135.37 54.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 62.53 110.846 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.452 HE21 ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER 179.67 -50.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 65.4 110.898 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 1.2 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 56.6 m -114.92 -162.54 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 71.35 110.898 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.6 OUTLIER -135.22 127.43 30.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 62.1 110.834 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -65.08 160.3 57.9 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.606 0.717 . . . . 75.1 110.885 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.0 Cg_endo -69.85 -9.55 11.25 Favored 'Cis proline' 0 C--O 1.232 0.177 0 C-N-CA 122.606 -1.831 . . . . 51.15 112.321 0.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -70.93 164.03 26.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 74.41 110.953 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -175.51 145.56 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 73.33 110.959 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.55 ' HG ' ' H ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -45.59 145.34 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 52.31 110.898 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.618 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER 179.98 169.78 0.66 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.677 0.751 . . . . 43.13 110.86 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 1.061 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.3 Cg_endo -69.78 -33.41 3.43 Favored 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.73 -1.779 . . . . 74.41 112.297 0.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.061 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.8 Cg_endo -69.78 -162.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.693 2.262 . . . . 50.0 112.341 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 tt -95.3 -34.73 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 71.24 111.144 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.8 m-30 -113.45 79.36 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 74.31 110.951 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.55 ' H ' ' HG ' ' A' ' 21' ' ' CYS . . . -146.49 -124.18 1.56 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 72.32 112.517 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -121.47 148.43 44.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 65.12 110.83 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.73 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 16.5 m -66.45 147.04 53.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 75.4 110.931 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.448 ' HB ' ' HG ' ' A' ' 22' ' ' SER . 47.2 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 73.31 111.094 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.93 0.395 . . . . 75.23 110.824 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.574 ' CG1' ' HG ' ' A' ' 29' ' ' CYS . 97.5 t -98.14 136.34 21.03 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.661 0.743 . . . . 64.54 111.113 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.439 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.8 Cg_endo -69.83 -91.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.619 2.212 . . . . 54.11 112.372 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.439 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 3.3 tt0 -146.54 146.66 30.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.425 . . . . 74.22 110.91 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 57.5 43.42 22.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 65.15 110.849 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -120.57 28.36 6.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.74 . . . . 72.52 112.467 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.503 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 p 35.84 83.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.363 . . . . 53.53 111.102 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 p -102.75 169.86 8.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 51.33 110.923 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -155.01 119.47 4.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 71.34 110.872 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.99 175.29 28.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 73.42 112.492 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.7 tp -109.18 -43.4 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 64.02 111.164 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.1 mt -109.97 -57.78 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 74.23 111.134 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -106.16 122.83 47.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 75.24 110.873 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 176.76 -46.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.151 -0.477 . . . . 73.44 110.939 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 20' ' ' TYR . 69.7 m -113.06 -162.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 71.25 110.894 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.413 ' H ' ' HB3' ' A' ' 15' ' ' CYS . 0.8 OUTLIER -135.09 137.23 42.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 64.31 110.974 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.554 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 10.3 m-20 -59.21 150.79 61.28 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 64.15 110.793 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.554 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.68 -22.96 9.26 Favored 'Cis proline' 0 C--N 1.342 0.235 0 C-N-CA 122.678 -1.801 . . . . 75.02 112.348 -0.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -51.35 163.59 0.25 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 73.33 110.968 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.414 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -171.39 30.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.5 . . . . 72.45 110.894 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.542 ' HG ' ' H ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER 64.59 143.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 61.44 110.866 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.621 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 173.75 171.81 0.25 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.694 0.759 . . . . 71.44 110.836 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 1.065 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.9 Cg_endo -69.76 -33.53 3.38 Favored 'Cis proline' 0 C--O 1.231 0.164 0 C-N-CA 122.684 -1.798 . . . . 43.32 112.322 0.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.065 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 54.3 Cg_endo -69.67 -162.11 0.09 OUTLIER 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.674 2.25 . . . . 64.54 112.382 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.1 -36.81 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 71.02 111.098 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.5 m-30 -115.76 79.3 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.874 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.542 ' H ' ' HG ' ' A' ' 21' ' ' CYS . . . -143.22 -120.9 1.55 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.779 -0.724 . . . . 61.32 112.504 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 40.6 m-70 -117.4 150.39 38.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.863 0.363 . . . . 71.23 110.845 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.574 ' HG ' ' CG1' ' A' ' 2' ' ' VAL . 70.9 m -70.14 126.74 30.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 74.45 110.924 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.5 mm . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.13 -0.486 . . . . 73.55 111.122 179.978 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 1.283 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.953 0.406 . . . . 63.22 110.827 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.514 HG13 ' HD2' ' A' ' 3' ' ' PRO . 43.9 t -148.73 136.96 11.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.6 0.714 . . . . 53.42 111.125 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.514 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.4 Cg_endo -69.65 -91.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.716 2.277 . . . . 54.22 112.377 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 6.2 tt0 -145.38 147.45 32.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 71.1 110.932 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 57.01 44.68 22.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 74.24 110.916 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -113.72 23.51 13.2 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 73.13 112.447 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.469 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.3 p 35.62 85.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.83 0.348 . . . . 54.55 111.113 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.3 p -113.71 172.98 6.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 73.31 110.923 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -158.38 118.83 3.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 75.43 110.831 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.01 158.12 7.59 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.755 -0.736 . . . . 64.41 112.515 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.527 HG23 HD11 ' A' ' 25' ' ' ILE . 1.6 pp -109.64 -27.56 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 72.21 111.144 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.3 mt -89.33 -35.37 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 73.21 111.168 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -163.08 133.39 4.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 71.13 110.889 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.622 ' HG2' ' HG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -178.7 -31.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.474 . . . . 71.13 110.899 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.622 ' HG ' ' HG2' ' A' ' 14' ' ' GLN . 96.9 m -136.78 -166.73 1.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 73.51 110.926 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 1.283 ' SG ' ' SG ' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -130.46 149.57 52.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 72.34 110.919 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.532 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 1.7 p30 -66.52 156.31 86.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.65 0.738 . . . . 62.43 110.861 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.3 Cg_endo -69.78 -14.49 12.53 Favored 'Cis proline' 0 C--N 1.342 0.214 0 C-N-CA 122.694 -1.794 . . . . 71.24 112.375 0.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -63.74 170.19 3.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 74.3 110.915 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.78 35.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.878 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER 65.35 138.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 70.43 110.89 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.66 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 174.42 172.7 0.25 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.627 0.727 . . . . 72.3 110.867 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 1.011 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.8 Cg_endo -69.76 -32.29 4.02 Favored 'Cis proline' 0 C--N 1.341 0.176 0 C-N-CA 122.674 -1.803 . . . . 65.04 112.366 0.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.011 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.0 Cg_endo -69.82 -164.09 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.672 2.248 . . . . 71.43 112.359 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.56 HD12 ' CE1' ' A' ' 26' ' ' TYR . 4.0 tt -90.02 -38.89 11.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 74.44 111.181 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.56 ' CE1' HD12 ' A' ' 25' ' ' ILE . 14.4 m-30 -119.05 87.71 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 74.35 110.9 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.412 ' H ' ' HG ' ' A' ' 21' ' ' CYS . . . -151.73 -123.45 1.06 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.784 -0.722 . . . . 32.41 112.488 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.91 149.66 27.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 62.35 110.878 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 85.9 m -72.05 120.29 17.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 43.51 110.795 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.0 mm . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 74.42 111.088 179.891 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.851 0.358 . . . . 75.05 110.814 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.559 ' CG1' ' HG ' ' A' ' 29' ' ' CYS . 90.6 t -95.07 136.79 22.46 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.641 0.734 . . . . 72.43 111.18 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.459 ' HD2' HG12 ' A' ' 2' ' ' VAL . 53.7 Cg_endo -69.72 -92.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.712 2.275 . . . . 64.32 112.371 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.448 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 3.6 tt0 -146.4 146.74 30.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 54.15 110.889 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 58.48 41.28 22.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 74.24 110.943 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -117.56 27.99 7.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 61.01 112.46 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.505 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 p 35.7 82.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.946 0.403 . . . . 64.44 111.138 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.7 p -103.25 168.6 9.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 61.34 110.895 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.15 119.4 4.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 62.11 110.771 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.63 166.13 13.99 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.797 -0.716 . . . . 73.04 112.529 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.404 HG23 ' H ' ' A' ' 12' ' ' ILE . 0.5 OUTLIER -107.19 -44.44 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.728 0.299 . . . . 72.24 111.121 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.407 ' HA ' HD12 ' A' ' 12' ' ' ILE . 9.6 mm -85.29 -65.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 53.05 111.112 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -122.86 131.46 53.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 62.13 110.876 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.35 -25.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 64.53 110.966 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 20' ' ' TYR . 58.6 m -133.13 -164.25 1.45 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 65.21 110.894 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -137.23 139.99 41.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.463 . . . . 64.35 110.853 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.539 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 4.7 p30 -61.35 154.84 61.18 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.648 0.737 . . . . 74.42 110.78 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 55.2 Cg_endo -69.61 -12.31 11.85 Favored 'Cis proline' 0 C--O 1.232 0.205 0 C-N-CA 122.703 -1.791 . . . . 51.3 112.385 -0.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -65.02 168.42 6.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 72.11 110.888 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.406 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -175.09 34.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 71.31 110.875 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER 64.82 139.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 61.24 110.899 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.617 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 172.4 171.15 0.22 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.623 0.725 . . . . 73.35 110.895 -179.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 1.059 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 54.0 Cg_endo -69.78 -33.47 3.41 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.621 -1.824 . . . . 73.45 112.379 0.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.059 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.7 Cg_endo -69.75 -161.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.655 2.237 . . . . 71.34 112.33 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -96.17 -37.44 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 54.21 111.103 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.4 m-30 -116.24 77.51 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 73.43 110.915 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.18 -119.74 1.51 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 51.44 112.488 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -116.72 153.32 32.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 73.45 110.81 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.559 ' HG ' ' CG1' ' A' ' 2' ' ' VAL . 74.6 m -71.64 126.06 28.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 75.22 110.934 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 mm . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 72.43 111.171 179.931 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.916 0.389 . . . . 62.11 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.615 ' CG1' ' HG ' ' A' ' 29' ' ' CYS . 97.8 t -99.14 136.69 20.45 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.628 0.728 . . . . 75.35 111.131 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.458 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.0 Cg_endo -69.8 -92.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.627 2.218 . . . . 73.13 112.31 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.481 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 3.3 tt0 -146.26 145.84 30.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 75.1 110.942 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 58.02 41.98 23.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 62.43 110.889 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -120.25 29.09 6.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.791 -0.719 . . . . 62.51 112.519 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.508 ' O ' HG23 ' A' ' 7' ' ' VAL . 2.4 p 35.92 82.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.341 . . . . 74.12 111.14 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.4 p -101.64 169.34 8.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 41.12 110.917 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -156.35 119.21 4.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 73.1 110.883 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.26 166.14 17.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.7 -0.762 . . . . 24.41 112.473 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.431 HG23 ' H ' ' A' ' 12' ' ' ILE . 0.6 OUTLIER -112.31 -44.11 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.863 0.363 . . . . 73.35 111.109 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.462 HD13 ' HA ' ' A' ' 12' ' ' ILE . 9.3 mm -91.62 -63.7 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 74.45 111.142 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -120.61 134.23 55.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 73.02 110.882 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.88 -74.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 74.01 110.884 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 20' ' ' TYR . 60.7 m -80.42 -163.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 65.41 110.912 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.409 ' H ' ' HB3' ' A' ' 15' ' ' CYS . 0.8 OUTLIER -135.81 138.45 42.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 65.21 110.916 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.55 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 24.1 m-20 -59.61 152.14 58.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.604 0.716 . . . . 74.21 110.912 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.55 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.68 -19.11 11.29 Favored 'Cis proline' 0 C--N 1.342 0.219 0 C-N-CA 122.62 -1.825 . . . . 60.33 112.392 -0.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -56.44 167.26 0.72 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.443 . . . . 75.14 110.875 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.43 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -172.48 31.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 74.12 110.927 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 64.36 141.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.096 -0.502 . . . . 54.12 110.918 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.623 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 173.72 171.63 0.25 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.727 0.775 . . . . 60.54 110.796 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 1.061 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.1 Cg_endo -69.82 -33.36 3.46 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.669 -1.804 . . . . 73.53 112.364 0.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.061 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.3 Cg_endo -69.73 -162.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.722 2.281 . . . . 73.44 112.293 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.3 -37.34 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.466 . . . . 71.02 111.149 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.5 m-30 -115.88 77.92 1.14 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 71.42 110.921 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.478 ' H ' ' HG ' ' A' ' 21' ' ' CYS . . . -141.97 -120.52 1.61 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.727 -0.749 . . . . 60.54 112.496 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -117.35 151.42 37.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 73.11 110.849 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.615 ' HG ' ' CG1' ' A' ' 2' ' ' VAL . 70.8 m -71.33 126.65 30.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 71.24 110.875 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.7 mm . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 64.32 111.117 179.938 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.2 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.84 0.352 . . . . 63.01 110.874 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.522 ' CG1' ' HG ' ' A' ' 29' ' ' CYS . 86.8 t -95.44 135.73 23.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.58 0.705 . . . . 73.02 111.196 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.415 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.7 Cg_endo -69.76 -91.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.691 2.26 . . . . 73.4 112.353 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.436 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 6.6 tt0 -144.65 147.11 32.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 74.33 110.856 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 57.7 43.33 22.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 72.24 110.965 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -120.17 27.83 6.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 65.31 112.513 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 7' ' ' VAL . 2.3 p 35.68 85.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.922 0.391 . . . . 75.3 111.17 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.7 p -105.98 172.93 6.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 71.53 110.857 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -161.37 120.05 2.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 75.41 110.834 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.68 157.72 8.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.681 -0.771 . . . . 24.14 112.494 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.439 HG21 HG13 ' A' ' 25' ' ' ILE . 6.6 pt -114.7 -28.51 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.812 0.339 . . . . 74.42 111.152 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 12' ' ' ILE . 13.0 mm -75.39 -34.91 31.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 74.32 111.157 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -175.18 135.25 0.34 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 52.13 110.889 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.422 ' NE2' ' H ' ' A' ' 15' ' ' CYS . 0.1 OUTLIER 176.54 -61.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 71.42 110.962 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.422 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 92.8 m -90.64 -165.64 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 74.44 110.841 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.56 137.35 40.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 75.2 110.874 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.544 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 5.3 m-20 -58.77 149.86 61.68 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.667 0.746 . . . . 71.24 110.854 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.544 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.73 -23.36 9.09 Favored 'Cis proline' 0 C--N 1.342 0.196 0 C-N-CA 122.714 -1.786 . . . . 71.02 112.284 -0.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -50.42 160.65 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 74.15 110.938 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.5 32.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 71.24 110.937 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.566 ' HG ' ' H ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER 65.08 143.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 74.23 110.862 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.638 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 173.8 170.65 0.26 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.683 0.754 . . . . 60.1 110.829 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 1.048 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 54.2 Cg_endo -69.69 -33.02 3.55 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.748 -1.772 . . . . 61.25 112.364 -0.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.048 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.9 Cg_endo -69.81 -161.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.623 2.215 . . . . 71.45 112.402 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.439 HG13 HG21 ' A' ' 11' ' ' ILE . 1.5 tt -97.23 -35.81 5.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 75.21 111.117 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -116.19 76.74 1.04 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 71.22 110.919 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.566 ' H ' ' HG ' ' A' ' 21' ' ' CYS . . . -141.77 -120.58 1.63 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 62.14 112.48 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.436 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 43.8 m-70 -116.9 149.76 39.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.331 . . . . 63.52 110.914 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 77.1 m -68.71 128.18 35.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 62.22 110.842 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.3 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.493 . . . . 72.11 111.154 179.931 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.934 0.397 . . . . 65.45 110.795 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.581 HG11 ' HG ' ' A' ' 29' ' ' CYS . 96.4 t -90.98 136.87 27.01 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 75.41 111.138 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.46 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.0 Cg_endo -69.71 -91.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.693 2.262 . . . . 65.14 112.374 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -147.12 154.62 41.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 54.15 110.912 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 64.37 14.9 9.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 71.52 110.938 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.7 114.57 4.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 64.4 112.465 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 7' ' ' VAL . 2.7 p -43.36 105.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.839 0.352 . . . . 65.44 111.197 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.0 p -123.32 167.9 13.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 52.23 110.84 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -159.63 108.86 1.83 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.102 -0.499 . . . . 73.34 110.897 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.9 159.15 9.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.66 -0.781 . . . . 72.44 112.416 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -101.66 -43.54 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.774 0.321 . . . . 70.5 111.114 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 12' ' ' ILE . 7.6 mm -84.01 -62.92 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 71.51 111.142 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -123.79 123.67 40.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 71.54 110.945 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -177.88 -33.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 74.13 110.883 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.429 ' HB3' ' H ' ' A' ' 16' ' ' CYS . 79.6 m -129.87 -162.15 1.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 73.12 110.974 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.429 ' H ' ' HB3' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -135.83 135.84 40.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 71.13 110.946 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.537 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 90.2 m-20 -59.36 154.76 40.86 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.617 0.723 . . . . 63.41 110.8 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.537 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.8 -16.0 12.39 Favored 'Cis proline' 0 C--N 1.342 0.188 0 C-N-CA 122.679 -1.8 . . . . 73.52 112.368 0.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -59.01 169.05 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 73.52 110.921 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.26 38.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 74.03 110.966 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 64.17 147.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 63.22 110.853 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.68 ' CB ' ' HA ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER 174.75 175.65 0.22 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.617 0.723 . . . . 53.32 110.843 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.941 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.2 Cg_endo -69.82 -31.64 4.44 Favored 'Cis proline' 0 C--O 1.232 0.204 0 C-N-CA 122.675 -1.802 . . . . 53.41 112.327 -0.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.941 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.5 Cg_endo -69.76 -92.02 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.688 2.259 . . . . 64.32 112.346 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -168.81 -34.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 73.44 111.122 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.4 m-30 -109.93 66.51 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 64.11 110.962 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.64 -110.55 0.64 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.826 -0.702 . . . . 63.25 112.559 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -111.93 149.35 32.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 70.45 110.865 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.581 ' HG ' HG11 ' A' ' 2' ' ' VAL . 90.8 m -72.97 120.8 19.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 73.03 110.889 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.9 mm . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 73.34 111.097 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 1.302 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.89 0.376 . . . . 75.31 110.845 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.464 HG12 ' HD2' ' A' ' 3' ' ' PRO . 57.5 t -150.71 136.02 10.25 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 53.1 111.173 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.464 ' HD2' HG12 ' A' ' 2' ' ' VAL . 54.6 Cg_endo -69.68 -92.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.746 2.297 . . . . 44.44 112.406 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -148.38 149.54 31.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 64.25 110.881 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 59.48 25.97 14.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 75.52 110.911 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -100.1 22.34 40.6 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.68 -0.771 . . . . 70.23 112.564 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.481 ' O ' HG23 ' A' ' 7' ' ' VAL . 2.3 p 35.92 85.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 44.31 111.102 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.6 p -109.51 169.06 8.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 62.34 110.875 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -153.34 117.77 4.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 72.33 110.838 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.32 156.75 7.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.709 -0.757 . . . . 64.23 112.425 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -98.64 -42.41 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 75.21 111.127 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.47 ' HA ' HD13 ' A' ' 12' ' ' ILE . 7.8 mm -89.01 -62.84 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.31 111.211 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -120.1 127.58 52.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 74.43 110.84 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.489 ' HG2' ' HG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -176.25 -34.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 75.03 110.944 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.489 ' HG ' ' HG2' ' A' ' 14' ' ' GLN . 97.7 m -133.96 -167.06 1.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 71.12 110.899 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 1.302 ' SG ' ' SG ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -132.99 157.79 44.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 75.2 110.867 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.523 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -72.2 156.82 90.25 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.609 0.719 . . . . 64.52 110.863 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.7 -12.56 12.11 Favored 'Cis proline' 0 C--N 1.341 0.182 0 C-N-CA 122.718 -1.784 . . . . 64.01 112.343 -0.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -66.0 176.58 1.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 75.52 110.871 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.97 36.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 70.11 110.857 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 65.14 136.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.468 . . . . 74.04 110.872 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.624 ' CB ' ' HA ' ' A' ' 23' ' ' PRO . 0.5 OUTLIER 169.73 173.29 0.13 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.672 0.749 . . . . 71.12 110.846 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 1.029 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.0 Cg_endo -69.76 -33.14 3.52 Favored 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.715 -1.785 . . . . 62.13 112.337 -0.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 1.029 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 54.1 Cg_endo -69.74 -161.46 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.641 2.227 . . . . 53.52 112.435 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.07 -33.65 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.306 -0.406 . . . . 55.13 111.161 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.2 m-85 -122.42 68.44 0.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 72.32 110.922 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -138.81 -117.79 1.54 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.792 -0.718 . . . . 55.13 112.533 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.472 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 54.2 m-70 -104.2 -177.05 3.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 63.14 110.863 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 98.4 m -107.66 121.48 44.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 73.32 110.897 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.6 mm . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 73.15 111.088 179.942 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 23.4 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.862 0.363 . . . . 34.240000000000002 110.954 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.586 HG13 ' HD2' ' A' ' 3' ' ' PRO . 79.3 t -90.8 136.69 27.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.532 0.682 . . . . 61.299999999999997 111.166 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.586 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.5 Cg_endo -69.79 -88.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.63 2.22 . . . . 71.310000000000002 112.349 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -151.25 148.62 28.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 74.439999999999998 110.901 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 67.07 13.38 9.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 73.200000000000003 110.885 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.2 114.26 4.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 75.430000000000007 112.489 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 7' ' ' VAL . 2.7 p -45.89 104.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.898 0.38 . . . . 61.140000000000001 111.112 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 5.0 p -121.8 172.36 8.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 73.310000000000002 110.889 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.93 118.74 4.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 63.539999999999999 110.931 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.81 174.67 30.93 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 50.219999999999999 112.456 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.533 ' O ' HD12 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -109.43 -42.49 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.333 . . . . 71.319999999999993 111.108 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 65.2 mt -109.92 -57.79 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 72.209999999999994 111.122 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -107.52 119.27 38.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 72.129999999999995 110.944 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 179.87 -31.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 74.109999999999999 110.91 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 33.1 m -126.85 -164.02 1.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 73.140000000000001 110.901 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -135.63 131.11 35.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.455 . . . . 74.329999999999998 110.872 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.495 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -69.09 160.24 79.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.544 0.688 . . . . 72.140000000000001 110.882 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.4 Cg_endo -69.79 -9.84 11.26 Favored 'Cis proline' 0 C--O 1.232 0.213 0 C-N-CA 122.681 -1.8 . . . . 73.409999999999997 112.316 0.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.2 163.51 26.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 72.120000000000005 110.919 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -173.05 146.45 1.49 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 75.319999999999993 110.915 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -48.05 145.37 3.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 62.43 110.899 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.66 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 174.95 171.2 0.29 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.733 0.777 . . . . 54.109999999999999 110.877 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.988 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.9 Cg_endo -69.71 -32.13 4.1 Favored 'Cis proline' 0 C--N 1.342 0.214 0 C-N-CA 122.649 -1.813 . . . . 74.409999999999997 112.382 -0.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.988 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 54.4 Cg_endo -69.78 -163.03 0.1 OUTLIER 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.691 2.261 . . . . 73.209999999999994 112.346 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -93.21 -38.1 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 60.329999999999998 111.111 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.7 m-30 -115.02 82.93 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 74.299999999999997 110.9 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -147.9 -121.12 1.2 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.645 -0.788 . . . . 54.539999999999999 112.443 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -122.4 151.77 40.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 70.030000000000001 110.823 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 13.1 m -75.38 148.41 39.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 73.099999999999994 110.875 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.731 HD13 ' O ' ' A' ' 29' ' ' CYS . 38.4 mm . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 71.230000000000004 111.167 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.88 0.372 . . . . 74.099999999999994 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.596 HG13 ' HD2' ' A' ' 3' ' ' PRO . 85.1 t -102.33 137.11 19.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 75.129999999999995 111.178 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.596 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.5 Cg_endo -69.73 -87.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.718 2.279 . . . . 71.150000000000006 112.348 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -148.68 151.02 34.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 74.25 110.956 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 64.7 28.4 13.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 72.120000000000005 110.898 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.421 ' HA3' HG11 ' A' ' 2' ' ' VAL . . . -116.88 119.15 4.38 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.737 -0.744 . . . . 63.350000000000001 112.516 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 7' ' ' VAL . 5.9 p -49.36 121.5 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.846 0.355 . . . . 62.119999999999997 111.1 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 1.1 p -140.15 163.42 32.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 71.519999999999996 110.917 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -154.35 111.5 3.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 64.299999999999997 110.872 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.658 ' N ' HE21 ' A' ' 14' ' ' GLN . . . 145.95 156.59 6.94 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 73.040000000000006 112.514 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.3 pt -111.85 -30.08 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.742 0.306 . . . . 64.340000000000003 111.149 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.2 mm -72.28 -34.27 48.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 62.119999999999997 111.114 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -176.88 142.42 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 61.310000000000002 110.902 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.658 HE21 ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER 174.29 -58.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 75.239999999999995 110.853 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 6.4 m -92.36 -166.65 1.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 73.140000000000001 110.809 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -135.92 128.96 31.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 64.530000000000001 110.938 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.502 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -67.89 160.39 74.12 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.619 0.723 . . . . 62.100000000000001 110.813 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 52.7 Cg_endo -69.86 -8.95 10.96 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.725 -1.781 . . . . 71.239999999999995 112.312 0.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -71.22 162.65 29.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 72.219999999999999 110.953 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -174.49 145.6 0.97 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 70.239999999999995 110.909 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -45.23 147.23 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 75.409999999999997 110.897 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.646 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER 177.56 170.34 0.44 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.713 . . . . 64.329999999999998 110.884 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 1.009 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 54.0 Cg_endo -69.7 -32.57 3.83 Favored 'Cis proline' 0 C--O 1.231 0.161 0 C-N-CA 122.664 -1.807 . . . . 74.319999999999993 112.365 -0.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.009 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.7 Cg_endo -69.81 -162.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.697 2.264 . . . . 74.010000000000005 112.334 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 26' ' ' TYR . 1.4 tt -93.13 -40.98 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 73.129999999999995 111.171 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.424 ' N ' HG23 ' A' ' 25' ' ' ILE . 6.4 m-30 -109.56 79.22 1.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 74.310000000000002 110.93 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.61 -124.77 1.86 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.748 . . . . 61.119999999999997 112.488 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -121.14 147.21 45.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.372 . . . . 72.010000000000005 110.849 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.739 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 17.9 m -65.54 146.65 54.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 64.540000000000006 110.86 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.648 HD13 ' O ' ' A' ' 29' ' ' CYS . 45.5 mm . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 71.030000000000001 111.139 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.86 0.362 . . . . 72.25 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.605 HG13 ' HD2' ' A' ' 3' ' ' PRO . 95.9 t -91.06 136.87 26.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.555 0.693 . . . . 72.340000000000003 111.171 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.605 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.4 Cg_endo -69.78 -92.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.668 2.245 . . . . 75.140000000000001 112.381 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.483 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 1.8 tt0 -146.47 145.4 30.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 74.049999999999997 110.916 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 58.92 25.99 14.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.42 . . . . 72.040000000000006 110.898 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -100.67 29.2 12.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 72.420000000000002 112.432 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.518 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 p 35.49 82.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 65.019999999999996 111.155 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.2 p -103.05 170.5 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 72.329999999999998 110.844 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.404 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.82 114.51 3.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 43.32 110.886 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.36 161.3 10.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 73.019999999999996 112.512 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.562 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -105.36 -44.51 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 61.049999999999997 111.143 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.8 mm -84.1 -64.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 72.219999999999999 111.186 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -126.66 127.15 44.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.030000000000001 110.859 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -178.39 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 71.040000000000006 110.923 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.1 m -120.94 -165.98 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 62.25 110.886 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -136.57 137.74 40.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 61.329999999999998 110.932 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.532 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 3.1 p30 -60.15 155.23 46.53 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.556 0.694 . . . . 64.349999999999994 110.879 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.84 -11.77 12.15 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.594 -1.836 . . . . 61.43 112.35 0.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -65.56 169.19 6.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.334 -0.394 . . . . 71.310000000000002 110.893 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -172.62 33.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.506 . . . . 75.230000000000004 110.913 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER 65.45 135.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 65.040000000000006 110.871 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.628 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 174.75 171.7 0.27 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.678 0.752 . . . . 61.130000000000003 110.852 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 1.025 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.6 Cg_endo -69.78 -32.91 3.64 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.729 -1.779 . . . . 73.140000000000001 112.376 -0.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.025 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.7 Cg_endo -69.76 -161.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.662 2.241 . . . . 74.450000000000003 112.323 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.32 -36.62 6.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 53.229999999999997 111.108 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.404 ' CE2' ' HB2' ' A' ' 9' ' ' ASP . 3.2 m-85 -117.89 77.64 1.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.540000000000006 110.93 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.01 -119.18 1.4 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.755 . . . . 52.439999999999998 112.448 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -116.34 153.33 32.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.818 0.342 . . . . 70.310000000000002 110.805 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.721 ' O ' HD13 ' A' ' 30' ' ' ILE . 76.5 m -73.07 125.98 28.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 73.219999999999999 110.873 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.721 HD13 ' O ' ' A' ' 29' ' ' CYS . 11.3 mm . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 72.219999999999999 111.112 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.5 p . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.89 0.376 . . . . 40.219999999999999 110.944 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.607 HG13 ' HD2' ' A' ' 3' ' ' PRO . 68.0 t -105.69 137.51 19.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.628 0.728 . . . . 74.329999999999998 111.134 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.607 ' HD2' HG13 ' A' ' 2' ' ' VAL . 52.6 Cg_endo -69.79 -87.8 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.686 2.257 . . . . 72.209999999999994 112.297 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -150.09 151.01 32.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 64.409999999999997 110.913 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 64.74 24.98 12.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 75.530000000000001 110.941 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.73 114.91 3.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 62.310000000000002 112.51 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 7' ' ' VAL . 3.8 p -47.65 113.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 64.209999999999994 111.178 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 1.2 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 2.9 p -133.46 169.26 17.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 72.129999999999995 110.947 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -156.2 120.95 4.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.198 -0.455 . . . . 72.340000000000003 110.906 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.12 175.65 25.59 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.77 -0.729 . . . . 52.119999999999997 112.493 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.567 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -115.1 -46.69 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.84 0.353 . . . . 64.200000000000003 111.133 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 13' ' ' ASN . 9.6 mm -84.43 -66.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 61.299999999999997 111.078 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.432 ' N ' HG22 ' A' ' 12' ' ' ILE . 8.6 p30 -114.17 135.37 54.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 62.530000000000001 110.846 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.461 HE22 ' HB2' ' A' ' 21' ' ' CYS . 0.0 OUTLIER 179.67 -50.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 65.400000000000006 110.898 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 1.2 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 56.6 m -114.92 -162.54 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 71.349999999999994 110.898 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.6 OUTLIER -135.22 127.43 30.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 62.100000000000001 110.834 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.498 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -65.08 160.3 57.9 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.606 0.717 . . . . 75.099999999999994 110.885 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.0 Cg_endo -69.85 -9.55 11.25 Favored 'Cis proline' 0 C--O 1.232 0.177 0 C-N-CA 122.606 -1.831 . . . . 51.149999999999999 112.321 0.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -70.93 164.03 26.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 74.409999999999997 110.953 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -175.51 145.56 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 73.329999999999998 110.959 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -45.59 145.34 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 52.310000000000002 110.898 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.615 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER 179.98 169.78 0.66 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.677 0.751 . . . . 43.130000000000003 110.86 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 1.049 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.3 Cg_endo -69.78 -33.41 3.43 Favored 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.73 -1.779 . . . . 74.409999999999997 112.297 0.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.049 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.8 Cg_endo -69.78 -162.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.693 2.262 . . . . 50.0 112.341 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 tt -95.3 -34.73 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 71.239999999999995 111.144 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.8 m-30 -113.45 79.36 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 74.310000000000002 110.951 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.49 -124.18 1.56 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 72.319999999999993 112.517 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -121.47 148.43 44.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 65.120000000000005 110.83 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.73 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 16.5 m -66.45 147.04 53.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 75.400000000000006 110.931 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 29' ' ' CYS . 47.2 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 73.310000000000002 111.094 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.93 0.395 . . . . 75.230000000000004 110.824 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.583 HG13 ' HD2' ' A' ' 3' ' ' PRO . 97.5 t -98.14 136.34 21.03 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.661 0.743 . . . . 64.540000000000006 111.113 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.583 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.8 Cg_endo -69.83 -91.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.619 2.212 . . . . 54.109999999999999 112.372 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.449 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 3.3 tt0 -146.54 146.66 30.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.425 . . . . 74.219999999999999 110.91 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 57.5 43.42 22.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 65.150000000000006 110.849 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -120.57 28.36 6.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.74 . . . . 72.519999999999996 112.467 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.516 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 p 35.84 83.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.363 . . . . 53.530000000000001 111.102 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 p -102.75 169.86 8.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 51.329999999999998 110.923 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -155.01 119.47 4.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 71.340000000000003 110.872 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.99 175.29 28.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 73.420000000000002 112.492 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.7 tp -109.18 -43.4 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 64.019999999999996 111.164 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.1 mt -109.97 -57.78 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 74.230000000000004 111.134 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -106.16 122.83 47.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 75.239999999999995 110.873 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 176.76 -46.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 110.939 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 20' ' ' TYR . 69.7 m -113.06 -162.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 71.25 110.894 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.09 137.23 42.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 64.310000000000002 110.974 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.554 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 10.3 m-20 -59.21 150.79 61.28 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 64.150000000000006 110.793 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.554 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.68 -22.96 9.26 Favored 'Cis proline' 0 C--N 1.342 0.235 0 C-N-CA 122.678 -1.801 . . . . 75.019999999999996 112.348 -0.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -51.35 163.59 0.25 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 73.329999999999998 110.968 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.422 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -171.39 30.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.5 . . . . 72.450000000000003 110.894 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 64.59 143.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 61.439999999999998 110.866 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.616 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 173.75 171.81 0.25 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.694 0.759 . . . . 71.439999999999998 110.836 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 1.042 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.9 Cg_endo -69.76 -33.53 3.38 Favored 'Cis proline' 0 C--O 1.231 0.164 0 C-N-CA 122.684 -1.798 . . . . 43.32 112.322 0.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.042 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 54.3 Cg_endo -69.67 -162.11 0.09 OUTLIER 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.674 2.25 . . . . 64.540000000000006 112.382 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.1 -36.81 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 71.019999999999996 111.098 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.5 m-30 -115.76 79.3 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 73.230000000000004 110.874 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.22 -120.9 1.55 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.779 -0.724 . . . . 61.32 112.504 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 40.6 m-70 -117.4 150.39 38.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.863 0.363 . . . . 71.230000000000004 110.845 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.713 ' O ' HD13 ' A' ' 30' ' ' ILE . 70.9 m -70.14 126.74 30.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 74.450000000000003 110.924 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.713 HD13 ' O ' ' A' ' 29' ' ' CYS . 15.5 mm . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.13 -0.486 . . . . 73.549999999999997 111.122 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 1.283 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.953 0.406 . . . . 63.219999999999999 110.827 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.557 HG13 ' HD2' ' A' ' 3' ' ' PRO . 43.9 t -148.73 136.96 11.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.6 0.714 . . . . 53.420000000000002 111.125 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.557 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.4 Cg_endo -69.65 -91.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.716 2.277 . . . . 54.219999999999999 112.377 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.436 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 6.2 tt0 -145.38 147.45 32.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 71.099999999999994 110.932 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 57.01 44.68 22.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 74.239999999999995 110.916 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -113.72 23.51 13.2 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 73.129999999999995 112.447 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.483 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.3 p 35.62 85.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.83 0.348 . . . . 54.549999999999997 111.113 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.3 p -113.71 172.98 6.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 73.310000000000002 110.923 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -158.38 118.83 3.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 75.430000000000007 110.831 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.01 158.12 7.59 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.755 -0.736 . . . . 64.409999999999997 112.515 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.45 HG22 HG13 ' A' ' 25' ' ' ILE . 1.6 pp -109.64 -27.56 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 72.209999999999994 111.144 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.3 mt -89.33 -35.37 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 73.209999999999994 111.168 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -163.08 133.39 4.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 71.129999999999995 110.889 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.7 -31.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.474 . . . . 71.129999999999995 110.899 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.9 m -136.78 -166.73 1.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 73.510000000000005 110.926 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 1.283 ' SG ' ' SG ' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -130.46 149.57 52.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 110.919 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.531 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 1.7 p30 -66.52 156.31 86.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.65 0.738 . . . . 62.43 110.861 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.531 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.3 Cg_endo -69.78 -14.49 12.53 Favored 'Cis proline' 0 C--N 1.342 0.214 0 C-N-CA 122.694 -1.794 . . . . 71.239999999999995 112.375 0.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -63.74 170.19 3.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 74.299999999999997 110.915 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.78 35.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 74.219999999999999 110.878 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER 65.35 138.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 70.430000000000007 110.89 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.655 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 174.42 172.7 0.25 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.627 0.727 . . . . 72.299999999999997 110.867 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 1.002 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.8 Cg_endo -69.76 -32.29 4.02 Favored 'Cis proline' 0 C--N 1.341 0.176 0 C-N-CA 122.674 -1.803 . . . . 65.040000000000006 112.366 0.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.002 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.0 Cg_endo -69.82 -164.09 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.672 2.248 . . . . 71.430000000000007 112.359 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.45 HG13 HG22 ' A' ' 11' ' ' ILE . 4.0 tt -90.02 -38.89 11.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 74.439999999999998 111.181 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.405 ' N ' HG23 ' A' ' 25' ' ' ILE . 14.4 m-30 -119.05 87.71 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 74.349999999999994 110.9 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.73 -123.45 1.06 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.784 -0.722 . . . . 32.409999999999997 112.488 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.91 149.66 27.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 62.350000000000001 110.878 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.759 ' O ' HD13 ' A' ' 30' ' ' ILE . 85.9 m -72.05 120.29 17.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 43.509999999999998 110.795 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.759 HD13 ' O ' ' A' ' 29' ' ' CYS . 6.0 mm . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 74.420000000000002 111.088 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.851 0.358 . . . . 75.049999999999997 110.814 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.598 HG13 ' HD2' ' A' ' 3' ' ' PRO . 90.6 t -95.07 136.79 22.46 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.641 0.734 . . . . 72.430000000000007 111.18 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.598 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.7 Cg_endo -69.72 -92.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.712 2.275 . . . . 64.319999999999993 112.371 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 3.6 tt0 -146.4 146.74 30.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 54.149999999999999 110.889 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 58.48 41.28 22.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 74.239999999999995 110.943 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -117.56 27.99 7.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 61.009999999999998 112.46 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.518 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 p 35.7 82.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.946 0.403 . . . . 64.439999999999998 111.138 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.7 p -103.25 168.6 9.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 61.340000000000003 110.895 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.15 119.4 4.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 62.109999999999999 110.771 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.63 166.13 13.99 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.797 -0.716 . . . . 73.040000000000006 112.529 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.574 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -107.19 -44.44 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.728 0.299 . . . . 72.239999999999995 111.121 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 13' ' ' ASN . 9.6 mm -85.29 -65.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 53.049999999999997 111.112 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.424 ' N ' HG22 ' A' ' 12' ' ' ILE . 12.1 p30 -122.86 131.46 53.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 62.130000000000003 110.876 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.35 -25.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 64.530000000000001 110.966 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' HB2' ' HA ' ' A' ' 20' ' ' TYR . 58.6 m -133.13 -164.25 1.45 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 65.209999999999994 110.894 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.413 ' H ' ' HB3' ' A' ' 15' ' ' CYS . 0.6 OUTLIER -137.23 139.99 41.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.463 . . . . 64.349999999999994 110.853 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.536 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 4.7 p30 -61.35 154.84 61.18 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.648 0.737 . . . . 74.420000000000002 110.78 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.536 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 55.2 Cg_endo -69.61 -12.31 11.85 Favored 'Cis proline' 0 C--O 1.232 0.205 0 C-N-CA 122.703 -1.791 . . . . 51.299999999999997 112.385 -0.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -65.02 168.42 6.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 72.109999999999999 110.888 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.417 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -175.09 34.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 71.310000000000002 110.875 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER 64.82 139.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 61.240000000000002 110.899 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.612 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 172.4 171.15 0.22 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.623 0.725 . . . . 73.349999999999994 110.895 -179.808 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 1.052 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 54.0 Cg_endo -69.78 -33.47 3.41 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.621 -1.824 . . . . 73.450000000000003 112.379 0.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.052 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.7 Cg_endo -69.75 -161.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.655 2.237 . . . . 71.340000000000003 112.33 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -96.17 -37.44 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 54.210000000000001 111.103 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.4 m-30 -116.24 77.51 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 73.430000000000007 110.915 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.18 -119.74 1.51 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 51.439999999999998 112.488 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -116.72 153.32 32.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 73.450000000000003 110.81 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.727 ' O ' HD13 ' A' ' 30' ' ' ILE . 74.6 m -71.64 126.06 28.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 75.219999999999999 110.934 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.727 HD13 ' O ' ' A' ' 29' ' ' CYS . 10.2 mm . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 72.430000000000007 111.171 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.916 0.389 . . . . 62.109999999999999 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.598 HG13 ' HD2' ' A' ' 3' ' ' PRO . 97.8 t -99.14 136.69 20.45 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.628 0.728 . . . . 75.349999999999994 111.131 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.598 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.0 Cg_endo -69.8 -92.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.627 2.218 . . . . 73.129999999999995 112.31 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.49 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 3.3 tt0 -146.26 145.84 30.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 75.099999999999994 110.942 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 58.02 41.98 23.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 62.43 110.889 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -120.25 29.09 6.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.791 -0.719 . . . . 62.509999999999998 112.519 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.522 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 p 35.92 82.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.341 . . . . 74.120000000000005 111.14 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.4 p -101.64 169.34 8.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 41.119999999999997 110.917 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -156.35 119.21 4.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 73.099999999999994 110.883 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.26 166.14 17.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.7 -0.762 . . . . 24.41 112.473 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.558 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -112.31 -44.11 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.863 0.363 . . . . 73.349999999999994 111.109 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.3 mm -91.62 -63.7 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 74.450000000000003 111.142 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -120.61 134.23 55.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 73.019999999999996 110.882 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.88 -74.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 74.010000000000005 110.884 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.441 ' HB2' ' HA ' ' A' ' 20' ' ' TYR . 60.7 m -80.42 -163.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 65.409999999999997 110.912 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.81 138.45 42.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 65.209999999999994 110.916 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.549 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 24.1 m-20 -59.61 152.14 58.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.604 0.716 . . . . 74.209999999999994 110.912 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.549 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.68 -19.11 11.29 Favored 'Cis proline' 0 C--N 1.342 0.219 0 C-N-CA 122.62 -1.825 . . . . 60.329999999999998 112.392 -0.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -56.44 167.26 0.72 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.443 . . . . 75.140000000000001 110.875 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -172.48 31.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 74.120000000000005 110.927 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 64.36 141.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.096 -0.502 . . . . 54.119999999999997 110.918 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.618 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 173.72 171.63 0.25 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.727 0.775 . . . . 60.539999999999999 110.796 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 1.038 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.1 Cg_endo -69.82 -33.36 3.46 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.669 -1.804 . . . . 73.530000000000001 112.364 0.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.038 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.3 Cg_endo -69.73 -162.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.722 2.281 . . . . 73.439999999999998 112.293 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.3 -37.34 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.466 . . . . 71.019999999999996 111.149 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.5 m-30 -115.88 77.92 1.14 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 71.420000000000002 110.921 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.97 -120.52 1.61 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.727 -0.749 . . . . 60.539999999999999 112.496 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -117.35 151.42 37.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 73.109999999999999 110.849 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.724 ' O ' HD13 ' A' ' 30' ' ' ILE . 70.8 m -71.33 126.65 30.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 71.239999999999995 110.875 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 29' ' ' CYS . 12.7 mm . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 64.319999999999993 111.117 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.2 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.84 0.352 . . . . 63.009999999999998 110.874 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.552 HG13 ' HD2' ' A' ' 3' ' ' PRO . 86.8 t -95.44 135.73 23.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.58 0.705 . . . . 73.019999999999996 111.196 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.552 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.7 Cg_endo -69.76 -91.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.691 2.26 . . . . 73.400000000000006 112.353 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.448 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 6.6 tt0 -144.65 147.11 32.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 74.329999999999998 110.856 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 57.7 43.33 22.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 72.239999999999995 110.965 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -120.17 27.83 6.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 65.310000000000002 112.513 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.498 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.3 p 35.68 85.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.922 0.391 . . . . 75.299999999999997 111.17 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.7 p -105.98 172.93 6.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 71.530000000000001 110.857 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -161.37 120.05 2.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 75.409999999999997 110.834 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.68 157.72 8.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.681 -0.771 . . . . 24.140000000000001 112.494 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -114.7 -28.51 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.812 0.339 . . . . 74.420000000000002 111.152 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.0 mm -75.39 -34.91 31.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 74.319999999999993 111.157 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -175.18 135.25 0.34 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 52.130000000000003 110.889 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.455 ' NE2' ' H ' ' A' ' 15' ' ' CYS . 0.1 OUTLIER 176.54 -61.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 71.420000000000002 110.962 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.455 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 92.8 m -90.64 -165.64 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 74.439999999999998 110.841 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.56 137.35 40.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 75.200000000000003 110.874 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.546 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 5.3 m-20 -58.77 149.86 61.68 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.667 0.746 . . . . 71.239999999999995 110.854 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.546 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.73 -23.36 9.09 Favored 'Cis proline' 0 C--N 1.342 0.196 0 C-N-CA 122.714 -1.786 . . . . 71.019999999999996 112.284 -0.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -50.42 160.65 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 74.150000000000006 110.938 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.5 32.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 71.239999999999995 110.937 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 65.08 143.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 74.230000000000004 110.862 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.633 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 173.8 170.65 0.26 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.683 0.754 . . . . 60.100000000000001 110.829 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 1.03 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 54.2 Cg_endo -69.69 -33.02 3.55 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.748 -1.772 . . . . 61.25 112.364 -0.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.03 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.9 Cg_endo -69.81 -161.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.623 2.215 . . . . 71.450000000000003 112.402 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 tt -97.23 -35.81 5.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 75.209999999999994 111.117 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -116.19 76.74 1.04 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 71.219999999999999 110.919 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.77 -120.58 1.63 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 62.140000000000001 112.48 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 43.8 m-70 -116.9 149.76 39.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.331 . . . . 63.520000000000003 110.914 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.706 ' O ' HD13 ' A' ' 30' ' ' ILE . 77.1 m -68.71 128.18 35.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 62.219999999999999 110.842 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.706 HD13 ' O ' ' A' ' 29' ' ' CYS . 17.3 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.493 . . . . 72.109999999999999 111.154 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.934 0.397 . . . . 65.450000000000003 110.795 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 3' ' ' PRO . 96.4 t -90.98 136.87 27.01 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 75.409999999999997 111.138 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.0 Cg_endo -69.71 -91.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.693 2.262 . . . . 65.140000000000001 112.374 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -147.12 154.62 41.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 54.149999999999999 110.912 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 64.37 14.9 9.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 71.519999999999996 110.938 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.7 114.57 4.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 64.400000000000006 112.465 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 7' ' ' VAL . 2.7 p -43.36 105.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.839 0.352 . . . . 65.439999999999998 111.197 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.0 p -123.32 167.9 13.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 52.229999999999997 110.84 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.522 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -159.63 108.86 1.83 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.102 -0.499 . . . . 73.340000000000003 110.897 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.9 159.15 9.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.66 -0.781 . . . . 72.439999999999998 112.416 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.571 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -101.66 -43.54 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.774 0.321 . . . . 70.5 111.114 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 13' ' ' ASN . 7.6 mm -84.01 -62.92 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 71.510000000000005 111.142 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.414 ' N ' HG22 ' A' ' 12' ' ' ILE . 7.3 p-10 -123.79 123.67 40.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 71.540000000000006 110.945 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -177.88 -33.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 74.129999999999995 110.883 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.6 m -129.87 -162.15 1.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 73.120000000000005 110.974 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -135.83 135.84 40.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 71.129999999999995 110.946 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.535 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 90.2 m-20 -59.36 154.76 40.86 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.617 0.723 . . . . 63.409999999999997 110.8 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.535 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.8 -16.0 12.39 Favored 'Cis proline' 0 C--N 1.342 0.188 0 C-N-CA 122.679 -1.8 . . . . 73.519999999999996 112.368 0.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -59.01 169.05 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 73.519999999999996 110.921 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.26 38.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 74.030000000000001 110.966 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 64.17 147.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 63.219999999999999 110.853 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.713 ' CB ' ' HA ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER 174.75 175.65 0.22 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.617 0.723 . . . . 53.32 110.843 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.939 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.2 Cg_endo -69.82 -31.64 4.44 Favored 'Cis proline' 0 C--O 1.232 0.204 0 C-N-CA 122.675 -1.802 . . . . 53.409999999999997 112.327 -0.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.939 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.5 Cg_endo -69.76 -92.02 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.688 2.259 . . . . 64.319999999999993 112.346 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -168.81 -34.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 111.122 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.4 m-30 -109.93 66.51 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 64.109999999999999 110.962 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.64 -110.55 0.64 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.826 -0.702 . . . . 63.25 112.559 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -111.93 149.35 32.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 70.450000000000003 110.865 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.788 ' O ' HD13 ' A' ' 30' ' ' ILE . 90.8 m -72.97 120.8 19.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 73.030000000000001 110.889 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.788 HD13 ' O ' ' A' ' 29' ' ' CYS . 5.9 mm . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 73.340000000000003 111.097 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 1.302 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.89 0.376 . . . . 75.310000000000002 110.845 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.547 HG13 ' HD2' ' A' ' 3' ' ' PRO . 57.5 t -150.71 136.02 10.25 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 53.100000000000001 111.173 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.6 Cg_endo -69.68 -92.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.746 2.297 . . . . 44.439999999999998 112.406 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -148.38 149.54 31.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 64.25 110.881 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 59.48 25.97 14.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 75.519999999999996 110.911 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -100.1 22.34 40.6 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.68 -0.771 . . . . 70.230000000000004 112.564 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.493 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.3 p 35.92 85.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 44.310000000000002 111.102 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.6 p -109.51 169.06 8.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 62.340000000000003 110.875 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -153.34 117.77 4.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 72.329999999999998 110.838 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.32 156.75 7.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.709 -0.757 . . . . 64.230000000000004 112.425 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.546 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -98.64 -42.41 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 75.209999999999994 111.127 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 12' ' ' ILE . 7.8 mm -89.01 -62.84 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.310000000000002 111.211 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.402 ' N ' HG22 ' A' ' 12' ' ' ILE . 15.5 p-10 -120.1 127.58 52.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 74.430000000000007 110.84 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -176.25 -34.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 75.030000000000001 110.944 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.407 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 97.7 m -133.96 -167.06 1.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 71.120000000000005 110.899 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 1.302 ' SG ' ' SG ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -132.99 157.79 44.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 75.200000000000003 110.867 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.52 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -72.2 156.82 90.25 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.609 0.719 . . . . 64.519999999999996 110.863 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.7 -12.56 12.11 Favored 'Cis proline' 0 C--N 1.341 0.182 0 C-N-CA 122.718 -1.784 . . . . 64.010000000000005 112.343 -0.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -66.0 176.58 1.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 75.519999999999996 110.871 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.97 36.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 70.109999999999999 110.857 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 65.14 136.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.468 . . . . 74.040000000000006 110.872 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.655 ' CB ' ' HA ' ' A' ' 23' ' ' PRO . 0.5 OUTLIER 169.73 173.29 0.13 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.672 0.749 . . . . 71.120000000000005 110.846 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 1.036 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.0 Cg_endo -69.76 -33.14 3.52 Favored 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.715 -1.785 . . . . 62.130000000000003 112.337 -0.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.036 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 54.1 Cg_endo -69.74 -161.46 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.641 2.227 . . . . 53.520000000000003 112.435 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.07 -33.65 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.306 -0.406 . . . . 55.130000000000003 111.161 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.2 m-85 -122.42 68.44 0.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 72.319999999999993 110.922 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -138.81 -117.79 1.54 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.792 -0.718 . . . . 55.130000000000003 112.533 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.47 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 54.2 m-70 -104.2 -177.05 3.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 63.140000000000001 110.863 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.743 ' O ' HD13 ' A' ' 30' ' ' ILE . 98.4 m -107.66 121.48 44.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 73.319999999999993 110.897 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.743 HD13 ' O ' ' A' ' 29' ' ' CYS . 4.6 mm . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 73.150000000000006 111.088 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 23.4 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.862 0.363 . . . . 34.240000000000002 110.954 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.586 HG13 ' HD2' ' A' ' 3' ' ' PRO . 79.3 t -90.8 136.69 27.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.532 0.682 . . . . 61.299999999999997 111.166 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.586 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.5 Cg_endo -69.79 -88.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.63 2.22 . . . . 71.310000000000002 112.349 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -151.25 148.62 28.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 74.439999999999998 110.901 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 67.07 13.38 9.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 73.200000000000003 110.885 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.2 114.26 4.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 75.430000000000007 112.489 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 7' ' ' VAL . 2.7 p -45.89 104.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.898 0.38 . . . . 61.140000000000001 111.112 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 5.0 p -121.8 172.36 8.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 73.310000000000002 110.889 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.93 118.74 4.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 63.539999999999999 110.931 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.81 174.67 30.93 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 50.219999999999999 112.456 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.533 ' O ' HD12 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -109.43 -42.49 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.333 . . . . 71.319999999999993 111.108 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 65.2 mt -109.92 -57.79 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 72.209999999999994 111.122 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -107.52 119.27 38.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 72.129999999999995 110.944 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 179.87 -31.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 74.109999999999999 110.91 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 33.1 m -126.85 -164.02 1.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 73.140000000000001 110.901 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -135.63 131.11 35.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.455 . . . . 74.329999999999998 110.872 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.495 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -69.09 160.24 79.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.544 0.688 . . . . 72.140000000000001 110.882 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.4 Cg_endo -69.79 -9.84 11.26 Favored 'Cis proline' 0 C--O 1.232 0.213 0 C-N-CA 122.681 -1.8 . . . . 73.409999999999997 112.316 0.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.2 163.51 26.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 72.120000000000005 110.919 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -173.05 146.45 1.49 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 75.319999999999993 110.915 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -48.05 145.37 3.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 62.43 110.899 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.66 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 174.95 171.2 0.29 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.733 0.777 . . . . 54.109999999999999 110.877 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.988 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.9 Cg_endo -69.71 -32.13 4.1 Favored 'Cis proline' 0 C--N 1.342 0.214 0 C-N-CA 122.649 -1.813 . . . . 74.409999999999997 112.382 -0.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.988 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 54.4 Cg_endo -69.78 -163.03 0.1 OUTLIER 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.691 2.261 . . . . 73.209999999999994 112.346 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -93.21 -38.1 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 60.329999999999998 111.111 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.7 m-30 -115.02 82.93 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 74.299999999999997 110.9 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -147.9 -121.12 1.2 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.645 -0.788 . . . . 54.539999999999999 112.443 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -122.4 151.77 40.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 70.030000000000001 110.823 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 13.1 m -75.38 148.41 39.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 73.099999999999994 110.875 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.731 HD13 ' O ' ' A' ' 29' ' ' CYS . 38.4 mm . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 71.230000000000004 111.167 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.88 0.372 . . . . 74.099999999999994 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.596 HG13 ' HD2' ' A' ' 3' ' ' PRO . 85.1 t -102.33 137.11 19.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 75.129999999999995 111.178 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.596 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.5 Cg_endo -69.73 -87.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.718 2.279 . . . . 71.150000000000006 112.348 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -148.68 151.02 34.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 74.25 110.956 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 64.7 28.4 13.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 72.120000000000005 110.898 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.421 ' HA3' HG11 ' A' ' 2' ' ' VAL . . . -116.88 119.15 4.38 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.737 -0.744 . . . . 63.350000000000001 112.516 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 7' ' ' VAL . 5.9 p -49.36 121.5 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.846 0.355 . . . . 62.119999999999997 111.1 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 1.1 p -140.15 163.42 32.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 71.519999999999996 110.917 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -154.35 111.5 3.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 64.299999999999997 110.872 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.658 ' N ' HE21 ' A' ' 14' ' ' GLN . . . 145.95 156.59 6.94 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 73.040000000000006 112.514 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.3 pt -111.85 -30.08 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.742 0.306 . . . . 64.340000000000003 111.149 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.2 mm -72.28 -34.27 48.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 62.119999999999997 111.114 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -176.88 142.42 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 61.310000000000002 110.902 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.658 HE21 ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER 174.29 -58.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 75.239999999999995 110.853 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 6.4 m -92.36 -166.65 1.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 73.140000000000001 110.809 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -135.92 128.96 31.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 64.530000000000001 110.938 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.502 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -67.89 160.39 74.12 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.619 0.723 . . . . 62.100000000000001 110.813 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 52.7 Cg_endo -69.86 -8.95 10.96 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.725 -1.781 . . . . 71.239999999999995 112.312 0.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -71.22 162.65 29.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 72.219999999999999 110.953 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -174.49 145.6 0.97 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 70.239999999999995 110.909 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -45.23 147.23 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 75.409999999999997 110.897 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.646 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER 177.56 170.34 0.44 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.713 . . . . 64.329999999999998 110.884 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 1.009 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 54.0 Cg_endo -69.7 -32.57 3.83 Favored 'Cis proline' 0 C--O 1.231 0.161 0 C-N-CA 122.664 -1.807 . . . . 74.319999999999993 112.365 -0.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.009 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.7 Cg_endo -69.81 -162.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.697 2.264 . . . . 74.010000000000005 112.334 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 26' ' ' TYR . 1.4 tt -93.13 -40.98 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 73.129999999999995 111.171 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.424 ' N ' HG23 ' A' ' 25' ' ' ILE . 6.4 m-30 -109.56 79.22 1.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 74.310000000000002 110.93 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.61 -124.77 1.86 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.748 . . . . 61.119999999999997 112.488 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -121.14 147.21 45.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.372 . . . . 72.010000000000005 110.849 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.739 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 17.9 m -65.54 146.65 54.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 64.540000000000006 110.86 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.648 HD13 ' O ' ' A' ' 29' ' ' CYS . 45.5 mm . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 71.030000000000001 111.139 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.86 0.362 . . . . 72.25 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.605 HG13 ' HD2' ' A' ' 3' ' ' PRO . 95.9 t -91.06 136.87 26.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.555 0.693 . . . . 72.340000000000003 111.171 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.605 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.4 Cg_endo -69.78 -92.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.668 2.245 . . . . 75.140000000000001 112.381 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.483 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 1.8 tt0 -146.47 145.4 30.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 74.049999999999997 110.916 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 58.92 25.99 14.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.42 . . . . 72.040000000000006 110.898 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -100.67 29.2 12.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 72.420000000000002 112.432 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.518 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 p 35.49 82.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 65.019999999999996 111.155 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.2 p -103.05 170.5 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 72.329999999999998 110.844 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.404 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.82 114.51 3.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 43.32 110.886 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.36 161.3 10.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 73.019999999999996 112.512 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.562 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -105.36 -44.51 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 61.049999999999997 111.143 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.8 mm -84.1 -64.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 72.219999999999999 111.186 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -126.66 127.15 44.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.030000000000001 110.859 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -178.39 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 71.040000000000006 110.923 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.1 m -120.94 -165.98 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 62.25 110.886 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -136.57 137.74 40.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 61.329999999999998 110.932 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.532 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 3.1 p30 -60.15 155.23 46.53 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.556 0.694 . . . . 64.349999999999994 110.879 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.84 -11.77 12.15 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.594 -1.836 . . . . 61.43 112.35 0.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -65.56 169.19 6.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.334 -0.394 . . . . 71.310000000000002 110.893 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -172.62 33.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.506 . . . . 75.230000000000004 110.913 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER 65.45 135.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 65.040000000000006 110.871 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.628 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 174.75 171.7 0.27 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.678 0.752 . . . . 61.130000000000003 110.852 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 1.025 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.6 Cg_endo -69.78 -32.91 3.64 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.729 -1.779 . . . . 73.140000000000001 112.376 -0.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.025 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.7 Cg_endo -69.76 -161.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.662 2.241 . . . . 74.450000000000003 112.323 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.32 -36.62 6.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 53.229999999999997 111.108 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.404 ' CE2' ' HB2' ' A' ' 9' ' ' ASP . 3.2 m-85 -117.89 77.64 1.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.540000000000006 110.93 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.01 -119.18 1.4 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.755 . . . . 52.439999999999998 112.448 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -116.34 153.33 32.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.818 0.342 . . . . 70.310000000000002 110.805 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.721 ' O ' HD13 ' A' ' 30' ' ' ILE . 76.5 m -73.07 125.98 28.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 73.219999999999999 110.873 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.721 HD13 ' O ' ' A' ' 29' ' ' CYS . 11.3 mm . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 72.219999999999999 111.112 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.5 p . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.89 0.376 . . . . 40.219999999999999 110.944 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.607 HG13 ' HD2' ' A' ' 3' ' ' PRO . 68.0 t -105.69 137.51 19.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.628 0.728 . . . . 74.329999999999998 111.134 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.607 ' HD2' HG13 ' A' ' 2' ' ' VAL . 52.6 Cg_endo -69.79 -87.8 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.686 2.257 . . . . 72.209999999999994 112.297 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -150.09 151.01 32.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 64.409999999999997 110.913 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 64.74 24.98 12.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 75.530000000000001 110.941 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.73 114.91 3.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 62.310000000000002 112.51 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 7' ' ' VAL . 3.8 p -47.65 113.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 64.209999999999994 111.178 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 1.2 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 2.9 p -133.46 169.26 17.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 72.129999999999995 110.947 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -156.2 120.95 4.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.198 -0.455 . . . . 72.340000000000003 110.906 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.12 175.65 25.59 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.77 -0.729 . . . . 52.119999999999997 112.493 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.567 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -115.1 -46.69 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.84 0.353 . . . . 64.200000000000003 111.133 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 13' ' ' ASN . 9.6 mm -84.43 -66.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 61.299999999999997 111.078 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.432 ' N ' HG22 ' A' ' 12' ' ' ILE . 8.6 p30 -114.17 135.37 54.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 62.530000000000001 110.846 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.461 HE22 ' HB2' ' A' ' 21' ' ' CYS . 0.0 OUTLIER 179.67 -50.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 65.400000000000006 110.898 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 1.2 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 56.6 m -114.92 -162.54 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 71.349999999999994 110.898 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.6 OUTLIER -135.22 127.43 30.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 62.100000000000001 110.834 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.498 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -65.08 160.3 57.9 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.606 0.717 . . . . 75.099999999999994 110.885 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.0 Cg_endo -69.85 -9.55 11.25 Favored 'Cis proline' 0 C--O 1.232 0.177 0 C-N-CA 122.606 -1.831 . . . . 51.149999999999999 112.321 0.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -70.93 164.03 26.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 74.409999999999997 110.953 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -175.51 145.56 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 73.329999999999998 110.959 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -45.59 145.34 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 52.310000000000002 110.898 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.615 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER 179.98 169.78 0.66 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.677 0.751 . . . . 43.130000000000003 110.86 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 1.049 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.3 Cg_endo -69.78 -33.41 3.43 Favored 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.73 -1.779 . . . . 74.409999999999997 112.297 0.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.049 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.8 Cg_endo -69.78 -162.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.693 2.262 . . . . 50.0 112.341 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 tt -95.3 -34.73 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 71.239999999999995 111.144 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.8 m-30 -113.45 79.36 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 74.310000000000002 110.951 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.49 -124.18 1.56 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 72.319999999999993 112.517 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -121.47 148.43 44.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 65.120000000000005 110.83 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.73 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 16.5 m -66.45 147.04 53.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 75.400000000000006 110.931 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 29' ' ' CYS . 47.2 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 73.310000000000002 111.094 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.93 0.395 . . . . 75.230000000000004 110.824 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.583 HG13 ' HD2' ' A' ' 3' ' ' PRO . 97.5 t -98.14 136.34 21.03 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.661 0.743 . . . . 64.540000000000006 111.113 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.583 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.8 Cg_endo -69.83 -91.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.619 2.212 . . . . 54.109999999999999 112.372 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.449 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 3.3 tt0 -146.54 146.66 30.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.425 . . . . 74.219999999999999 110.91 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 57.5 43.42 22.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 65.150000000000006 110.849 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -120.57 28.36 6.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.74 . . . . 72.519999999999996 112.467 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.516 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 p 35.84 83.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.363 . . . . 53.530000000000001 111.102 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 p -102.75 169.86 8.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 51.329999999999998 110.923 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -155.01 119.47 4.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 71.340000000000003 110.872 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.99 175.29 28.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 73.420000000000002 112.492 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.7 tp -109.18 -43.4 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 64.019999999999996 111.164 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.1 mt -109.97 -57.78 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 74.230000000000004 111.134 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -106.16 122.83 47.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 75.239999999999995 110.873 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 176.76 -46.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 110.939 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 20' ' ' TYR . 69.7 m -113.06 -162.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 71.25 110.894 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.09 137.23 42.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 64.310000000000002 110.974 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.554 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 10.3 m-20 -59.21 150.79 61.28 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 64.150000000000006 110.793 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.554 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.68 -22.96 9.26 Favored 'Cis proline' 0 C--N 1.342 0.235 0 C-N-CA 122.678 -1.801 . . . . 75.019999999999996 112.348 -0.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -51.35 163.59 0.25 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 73.329999999999998 110.968 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.422 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -171.39 30.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.5 . . . . 72.450000000000003 110.894 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 64.59 143.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 61.439999999999998 110.866 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.616 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 173.75 171.81 0.25 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.694 0.759 . . . . 71.439999999999998 110.836 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 1.042 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.9 Cg_endo -69.76 -33.53 3.38 Favored 'Cis proline' 0 C--O 1.231 0.164 0 C-N-CA 122.684 -1.798 . . . . 43.32 112.322 0.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.042 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 54.3 Cg_endo -69.67 -162.11 0.09 OUTLIER 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.674 2.25 . . . . 64.540000000000006 112.382 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.1 -36.81 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 71.019999999999996 111.098 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.5 m-30 -115.76 79.3 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 73.230000000000004 110.874 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.22 -120.9 1.55 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.779 -0.724 . . . . 61.32 112.504 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 40.6 m-70 -117.4 150.39 38.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.863 0.363 . . . . 71.230000000000004 110.845 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.713 ' O ' HD13 ' A' ' 30' ' ' ILE . 70.9 m -70.14 126.74 30.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 74.450000000000003 110.924 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.713 HD13 ' O ' ' A' ' 29' ' ' CYS . 15.5 mm . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.13 -0.486 . . . . 73.549999999999997 111.122 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 1.283 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.953 0.406 . . . . 63.219999999999999 110.827 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.557 HG13 ' HD2' ' A' ' 3' ' ' PRO . 43.9 t -148.73 136.96 11.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.6 0.714 . . . . 53.420000000000002 111.125 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.557 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.4 Cg_endo -69.65 -91.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.716 2.277 . . . . 54.219999999999999 112.377 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.436 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 6.2 tt0 -145.38 147.45 32.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 71.099999999999994 110.932 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 57.01 44.68 22.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 74.239999999999995 110.916 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -113.72 23.51 13.2 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 73.129999999999995 112.447 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.483 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.3 p 35.62 85.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.83 0.348 . . . . 54.549999999999997 111.113 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.3 p -113.71 172.98 6.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 73.310000000000002 110.923 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -158.38 118.83 3.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 75.430000000000007 110.831 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.01 158.12 7.59 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.755 -0.736 . . . . 64.409999999999997 112.515 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.45 HG22 HG13 ' A' ' 25' ' ' ILE . 1.6 pp -109.64 -27.56 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 72.209999999999994 111.144 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.3 mt -89.33 -35.37 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 73.209999999999994 111.168 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -163.08 133.39 4.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 71.129999999999995 110.889 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.7 -31.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.474 . . . . 71.129999999999995 110.899 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.9 m -136.78 -166.73 1.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 73.510000000000005 110.926 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 1.283 ' SG ' ' SG ' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -130.46 149.57 52.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 110.919 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.531 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 1.7 p30 -66.52 156.31 86.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.65 0.738 . . . . 62.43 110.861 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.531 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.3 Cg_endo -69.78 -14.49 12.53 Favored 'Cis proline' 0 C--N 1.342 0.214 0 C-N-CA 122.694 -1.794 . . . . 71.239999999999995 112.375 0.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -63.74 170.19 3.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 74.299999999999997 110.915 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.78 35.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 74.219999999999999 110.878 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER 65.35 138.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 70.430000000000007 110.89 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.655 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 174.42 172.7 0.25 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.627 0.727 . . . . 72.299999999999997 110.867 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 1.002 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.8 Cg_endo -69.76 -32.29 4.02 Favored 'Cis proline' 0 C--N 1.341 0.176 0 C-N-CA 122.674 -1.803 . . . . 65.040000000000006 112.366 0.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.002 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.0 Cg_endo -69.82 -164.09 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.672 2.248 . . . . 71.430000000000007 112.359 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.45 HG13 HG22 ' A' ' 11' ' ' ILE . 4.0 tt -90.02 -38.89 11.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 74.439999999999998 111.181 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.405 ' N ' HG23 ' A' ' 25' ' ' ILE . 14.4 m-30 -119.05 87.71 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 74.349999999999994 110.9 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.73 -123.45 1.06 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.784 -0.722 . . . . 32.409999999999997 112.488 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.91 149.66 27.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 62.350000000000001 110.878 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.759 ' O ' HD13 ' A' ' 30' ' ' ILE . 85.9 m -72.05 120.29 17.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 43.509999999999998 110.795 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.759 HD13 ' O ' ' A' ' 29' ' ' CYS . 6.0 mm . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 74.420000000000002 111.088 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.851 0.358 . . . . 75.049999999999997 110.814 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.598 HG13 ' HD2' ' A' ' 3' ' ' PRO . 90.6 t -95.07 136.79 22.46 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.641 0.734 . . . . 72.430000000000007 111.18 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.598 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.7 Cg_endo -69.72 -92.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.712 2.275 . . . . 64.319999999999993 112.371 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 3.6 tt0 -146.4 146.74 30.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 54.149999999999999 110.889 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 58.48 41.28 22.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 74.239999999999995 110.943 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -117.56 27.99 7.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 61.009999999999998 112.46 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.518 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 p 35.7 82.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.946 0.403 . . . . 64.439999999999998 111.138 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.7 p -103.25 168.6 9.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 61.340000000000003 110.895 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.15 119.4 4.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 62.109999999999999 110.771 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.63 166.13 13.99 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.797 -0.716 . . . . 73.040000000000006 112.529 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.574 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -107.19 -44.44 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.728 0.299 . . . . 72.239999999999995 111.121 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 13' ' ' ASN . 9.6 mm -85.29 -65.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 53.049999999999997 111.112 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.424 ' N ' HG22 ' A' ' 12' ' ' ILE . 12.1 p30 -122.86 131.46 53.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 62.130000000000003 110.876 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.35 -25.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 64.530000000000001 110.966 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' HB2' ' HA ' ' A' ' 20' ' ' TYR . 58.6 m -133.13 -164.25 1.45 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 65.209999999999994 110.894 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.413 ' H ' ' HB3' ' A' ' 15' ' ' CYS . 0.6 OUTLIER -137.23 139.99 41.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.463 . . . . 64.349999999999994 110.853 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.536 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 4.7 p30 -61.35 154.84 61.18 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.648 0.737 . . . . 74.420000000000002 110.78 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.536 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 55.2 Cg_endo -69.61 -12.31 11.85 Favored 'Cis proline' 0 C--O 1.232 0.205 0 C-N-CA 122.703 -1.791 . . . . 51.299999999999997 112.385 -0.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -65.02 168.42 6.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 72.109999999999999 110.888 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.417 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -175.09 34.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 71.310000000000002 110.875 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER 64.82 139.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 61.240000000000002 110.899 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.612 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 172.4 171.15 0.22 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.623 0.725 . . . . 73.349999999999994 110.895 -179.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 1.052 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 54.0 Cg_endo -69.78 -33.47 3.41 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.621 -1.824 . . . . 73.450000000000003 112.379 0.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.052 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.7 Cg_endo -69.75 -161.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.655 2.237 . . . . 71.340000000000003 112.33 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -96.17 -37.44 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 54.210000000000001 111.103 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.4 m-30 -116.24 77.51 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 73.430000000000007 110.915 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.18 -119.74 1.51 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 51.439999999999998 112.488 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -116.72 153.32 32.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 73.450000000000003 110.81 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.727 ' O ' HD13 ' A' ' 30' ' ' ILE . 74.6 m -71.64 126.06 28.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 75.219999999999999 110.934 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.727 HD13 ' O ' ' A' ' 29' ' ' CYS . 10.2 mm . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 72.430000000000007 111.171 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.916 0.389 . . . . 62.109999999999999 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.598 HG13 ' HD2' ' A' ' 3' ' ' PRO . 97.8 t -99.14 136.69 20.45 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.628 0.728 . . . . 75.349999999999994 111.131 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.598 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.0 Cg_endo -69.8 -92.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.627 2.218 . . . . 73.129999999999995 112.31 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.49 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 3.3 tt0 -146.26 145.84 30.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 75.099999999999994 110.942 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 58.02 41.98 23.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 62.43 110.889 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -120.25 29.09 6.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.791 -0.719 . . . . 62.509999999999998 112.519 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.522 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 p 35.92 82.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.341 . . . . 74.120000000000005 111.14 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.4 p -101.64 169.34 8.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 41.119999999999997 110.917 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -156.35 119.21 4.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 73.099999999999994 110.883 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.26 166.14 17.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.7 -0.762 . . . . 24.41 112.473 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.558 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -112.31 -44.11 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.863 0.363 . . . . 73.349999999999994 111.109 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.3 mm -91.62 -63.7 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 74.450000000000003 111.142 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -120.61 134.23 55.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 73.019999999999996 110.882 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.88 -74.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 74.010000000000005 110.884 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.441 ' HB2' ' HA ' ' A' ' 20' ' ' TYR . 60.7 m -80.42 -163.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 65.409999999999997 110.912 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.81 138.45 42.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 65.209999999999994 110.916 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.549 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 24.1 m-20 -59.61 152.14 58.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.604 0.716 . . . . 74.209999999999994 110.912 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.549 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.68 -19.11 11.29 Favored 'Cis proline' 0 C--N 1.342 0.219 0 C-N-CA 122.62 -1.825 . . . . 60.329999999999998 112.392 -0.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -56.44 167.26 0.72 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.443 . . . . 75.140000000000001 110.875 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -172.48 31.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 74.120000000000005 110.927 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 64.36 141.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.096 -0.502 . . . . 54.119999999999997 110.918 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.618 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 173.72 171.63 0.25 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.727 0.775 . . . . 60.539999999999999 110.796 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 1.038 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.1 Cg_endo -69.82 -33.36 3.46 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.669 -1.804 . . . . 73.530000000000001 112.364 0.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.038 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.3 Cg_endo -69.73 -162.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.722 2.281 . . . . 73.439999999999998 112.293 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.3 -37.34 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.466 . . . . 71.019999999999996 111.149 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.5 m-30 -115.88 77.92 1.14 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 71.420000000000002 110.921 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.97 -120.52 1.61 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.727 -0.749 . . . . 60.539999999999999 112.496 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -117.35 151.42 37.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 73.109999999999999 110.849 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.724 ' O ' HD13 ' A' ' 30' ' ' ILE . 70.8 m -71.33 126.65 30.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 71.239999999999995 110.875 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 29' ' ' CYS . 12.7 mm . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 64.319999999999993 111.117 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.2 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.84 0.352 . . . . 63.009999999999998 110.874 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.552 HG13 ' HD2' ' A' ' 3' ' ' PRO . 86.8 t -95.44 135.73 23.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.58 0.705 . . . . 73.019999999999996 111.196 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.552 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.7 Cg_endo -69.76 -91.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.691 2.26 . . . . 73.400000000000006 112.353 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.448 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 6.6 tt0 -144.65 147.11 32.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 74.329999999999998 110.856 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 57.7 43.33 22.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 72.239999999999995 110.965 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -120.17 27.83 6.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 65.310000000000002 112.513 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.498 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.3 p 35.68 85.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.922 0.391 . . . . 75.299999999999997 111.17 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.7 p -105.98 172.93 6.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 71.530000000000001 110.857 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -161.37 120.05 2.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 75.409999999999997 110.834 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.68 157.72 8.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.681 -0.771 . . . . 24.140000000000001 112.494 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -114.7 -28.51 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.812 0.339 . . . . 74.420000000000002 111.152 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.0 mm -75.39 -34.91 31.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 74.319999999999993 111.157 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -175.18 135.25 0.34 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 52.130000000000003 110.889 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.455 ' NE2' ' H ' ' A' ' 15' ' ' CYS . 0.1 OUTLIER 176.54 -61.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 71.420000000000002 110.962 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.455 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 92.8 m -90.64 -165.64 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 74.439999999999998 110.841 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.56 137.35 40.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 75.200000000000003 110.874 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.546 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 5.3 m-20 -58.77 149.86 61.68 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.667 0.746 . . . . 71.239999999999995 110.854 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.546 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.73 -23.36 9.09 Favored 'Cis proline' 0 C--N 1.342 0.196 0 C-N-CA 122.714 -1.786 . . . . 71.019999999999996 112.284 -0.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -50.42 160.65 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 74.150000000000006 110.938 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.5 32.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 71.239999999999995 110.937 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 65.08 143.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 74.230000000000004 110.862 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.633 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 173.8 170.65 0.26 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.683 0.754 . . . . 60.100000000000001 110.829 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 1.03 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 54.2 Cg_endo -69.69 -33.02 3.55 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.748 -1.772 . . . . 61.25 112.364 -0.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.03 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.9 Cg_endo -69.81 -161.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.623 2.215 . . . . 71.450000000000003 112.402 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 tt -97.23 -35.81 5.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 75.209999999999994 111.117 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -116.19 76.74 1.04 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 71.219999999999999 110.919 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.77 -120.58 1.63 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 62.140000000000001 112.48 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 43.8 m-70 -116.9 149.76 39.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.331 . . . . 63.520000000000003 110.914 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.706 ' O ' HD13 ' A' ' 30' ' ' ILE . 77.1 m -68.71 128.18 35.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 62.219999999999999 110.842 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.706 HD13 ' O ' ' A' ' 29' ' ' CYS . 17.3 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.493 . . . . 72.109999999999999 111.154 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.934 0.397 . . . . 65.450000000000003 110.795 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 3' ' ' PRO . 96.4 t -90.98 136.87 27.01 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 75.409999999999997 111.138 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.0 Cg_endo -69.71 -91.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.693 2.262 . . . . 65.140000000000001 112.374 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -147.12 154.62 41.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 54.149999999999999 110.912 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 64.37 14.9 9.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 71.519999999999996 110.938 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.7 114.57 4.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 64.400000000000006 112.465 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 7' ' ' VAL . 2.7 p -43.36 105.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.839 0.352 . . . . 65.439999999999998 111.197 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.0 p -123.32 167.9 13.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 52.229999999999997 110.84 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.522 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -159.63 108.86 1.83 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.102 -0.499 . . . . 73.340000000000003 110.897 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.9 159.15 9.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.66 -0.781 . . . . 72.439999999999998 112.416 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.571 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -101.66 -43.54 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.774 0.321 . . . . 70.5 111.114 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 13' ' ' ASN . 7.6 mm -84.01 -62.92 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 71.510000000000005 111.142 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.414 ' N ' HG22 ' A' ' 12' ' ' ILE . 7.3 p-10 -123.79 123.67 40.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 71.540000000000006 110.945 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -177.88 -33.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 74.129999999999995 110.883 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.6 m -129.87 -162.15 1.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 73.120000000000005 110.974 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -135.83 135.84 40.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 71.129999999999995 110.946 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.535 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 90.2 m-20 -59.36 154.76 40.86 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.617 0.723 . . . . 63.409999999999997 110.8 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.535 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.8 -16.0 12.39 Favored 'Cis proline' 0 C--N 1.342 0.188 0 C-N-CA 122.679 -1.8 . . . . 73.519999999999996 112.368 0.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -59.01 169.05 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 73.519999999999996 110.921 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.26 38.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 74.030000000000001 110.966 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 64.17 147.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 63.219999999999999 110.853 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.713 ' CB ' ' HA ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER 174.75 175.65 0.22 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.617 0.723 . . . . 53.32 110.843 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.939 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.2 Cg_endo -69.82 -31.64 4.44 Favored 'Cis proline' 0 C--O 1.232 0.204 0 C-N-CA 122.675 -1.802 . . . . 53.409999999999997 112.327 -0.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.939 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.5 Cg_endo -69.76 -92.02 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.688 2.259 . . . . 64.319999999999993 112.346 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -168.81 -34.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 111.122 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.4 m-30 -109.93 66.51 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 64.109999999999999 110.962 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.64 -110.55 0.64 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.826 -0.702 . . . . 63.25 112.559 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -111.93 149.35 32.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 70.450000000000003 110.865 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.788 ' O ' HD13 ' A' ' 30' ' ' ILE . 90.8 m -72.97 120.8 19.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 73.030000000000001 110.889 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.788 HD13 ' O ' ' A' ' 29' ' ' CYS . 5.9 mm . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 73.340000000000003 111.097 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 1.302 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.89 0.376 . . . . 75.310000000000002 110.845 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.547 HG13 ' HD2' ' A' ' 3' ' ' PRO . 57.5 t -150.71 136.02 10.25 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 53.100000000000001 111.173 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.6 Cg_endo -69.68 -92.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.746 2.297 . . . . 44.439999999999998 112.406 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -148.38 149.54 31.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 64.25 110.881 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 59.48 25.97 14.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 75.519999999999996 110.911 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -100.1 22.34 40.6 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.68 -0.771 . . . . 70.230000000000004 112.564 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.493 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.3 p 35.92 85.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 44.310000000000002 111.102 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.6 p -109.51 169.06 8.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 62.340000000000003 110.875 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -153.34 117.77 4.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 72.329999999999998 110.838 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.32 156.75 7.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.709 -0.757 . . . . 64.230000000000004 112.425 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.546 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -98.64 -42.41 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 75.209999999999994 111.127 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 12' ' ' ILE . 7.8 mm -89.01 -62.84 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.310000000000002 111.211 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.402 ' N ' HG22 ' A' ' 12' ' ' ILE . 15.5 p-10 -120.1 127.58 52.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 74.430000000000007 110.84 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -176.25 -34.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 75.030000000000001 110.944 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.407 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 97.7 m -133.96 -167.06 1.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 71.120000000000005 110.899 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 1.302 ' SG ' ' SG ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -132.99 157.79 44.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 75.200000000000003 110.867 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.52 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -72.2 156.82 90.25 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.609 0.719 . . . . 64.519999999999996 110.863 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.7 -12.56 12.11 Favored 'Cis proline' 0 C--N 1.341 0.182 0 C-N-CA 122.718 -1.784 . . . . 64.010000000000005 112.343 -0.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -66.0 176.58 1.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 75.519999999999996 110.871 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.97 36.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 70.109999999999999 110.857 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 65.14 136.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.468 . . . . 74.040000000000006 110.872 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.655 ' CB ' ' HA ' ' A' ' 23' ' ' PRO . 0.5 OUTLIER 169.73 173.29 0.13 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.672 0.749 . . . . 71.120000000000005 110.846 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 1.036 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.0 Cg_endo -69.76 -33.14 3.52 Favored 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.715 -1.785 . . . . 62.130000000000003 112.337 -0.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.036 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 54.1 Cg_endo -69.74 -161.46 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.641 2.227 . . . . 53.520000000000003 112.435 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.07 -33.65 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.306 -0.406 . . . . 55.130000000000003 111.161 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.2 m-85 -122.42 68.44 0.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 72.319999999999993 110.922 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -138.81 -117.79 1.54 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.792 -0.718 . . . . 55.130000000000003 112.533 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.47 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 54.2 m-70 -104.2 -177.05 3.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 63.140000000000001 110.863 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.743 ' O ' HD13 ' A' ' 30' ' ' ILE . 98.4 m -107.66 121.48 44.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 73.319999999999993 110.897 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.743 HD13 ' O ' ' A' ' 29' ' ' CYS . 4.6 mm . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 73.150000000000006 111.088 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 23.4 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.862 0.363 . . . . 34.240000000000002 110.954 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.586 HG13 ' HD2' ' A' ' 3' ' ' PRO . 79.3 t -90.8 136.69 27.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.532 0.682 . . . . 61.299999999999997 111.166 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.586 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.5 Cg_endo -69.79 -88.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.63 2.22 . . . . 71.310000000000002 112.349 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -151.25 148.62 28.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 74.439999999999998 110.901 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 67.07 13.38 9.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 73.200000000000003 110.885 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.2 114.26 4.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 75.430000000000007 112.489 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 7' ' ' VAL . 2.7 p -45.89 104.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.898 0.38 . . . . 61.140000000000001 111.112 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 5.0 p -121.8 172.36 8.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 73.310000000000002 110.889 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.93 118.74 4.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 63.539999999999999 110.931 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.81 174.67 30.93 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 50.219999999999999 112.456 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.533 ' O ' HD12 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -109.43 -42.49 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.333 . . . . 71.319999999999993 111.108 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 65.2 mt -109.92 -57.79 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 72.209999999999994 111.122 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -107.52 119.27 38.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 72.129999999999995 110.944 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 179.87 -31.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 74.109999999999999 110.91 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 33.1 m -126.85 -164.02 1.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 73.140000000000001 110.901 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -135.63 131.11 35.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.455 . . . . 74.329999999999998 110.872 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.495 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -69.09 160.24 79.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.544 0.688 . . . . 72.140000000000001 110.882 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.4 Cg_endo -69.79 -9.84 11.26 Favored 'Cis proline' 0 C--O 1.232 0.213 0 C-N-CA 122.681 -1.8 . . . . 73.409999999999997 112.316 0.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.2 163.51 26.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 72.120000000000005 110.919 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -173.05 146.45 1.49 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 75.319999999999993 110.915 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -48.05 145.37 3.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 62.43 110.899 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.66 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 174.95 171.2 0.29 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.733 0.777 . . . . 54.109999999999999 110.877 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.988 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.9 Cg_endo -69.71 -32.13 4.1 Favored 'Cis proline' 0 C--N 1.342 0.214 0 C-N-CA 122.649 -1.813 . . . . 74.409999999999997 112.382 -0.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.988 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 54.4 Cg_endo -69.78 -163.03 0.1 OUTLIER 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.691 2.261 . . . . 73.209999999999994 112.346 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -93.21 -38.1 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 60.329999999999998 111.111 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.7 m-30 -115.02 82.93 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 74.299999999999997 110.9 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -147.9 -121.12 1.2 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.645 -0.788 . . . . 54.539999999999999 112.443 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -122.4 151.77 40.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 70.030000000000001 110.823 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 13.1 m -75.38 148.41 39.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 73.099999999999994 110.875 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.731 HD13 ' O ' ' A' ' 29' ' ' CYS . 38.4 mm . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 71.230000000000004 111.167 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.88 0.372 . . . . 74.099999999999994 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.596 HG13 ' HD2' ' A' ' 3' ' ' PRO . 85.1 t -102.33 137.11 19.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 75.129999999999995 111.178 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.596 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.5 Cg_endo -69.73 -87.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.718 2.279 . . . . 71.150000000000006 112.348 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -148.68 151.02 34.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 74.25 110.956 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 64.7 28.4 13.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 72.120000000000005 110.898 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.421 ' HA3' HG11 ' A' ' 2' ' ' VAL . . . -116.88 119.15 4.38 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.737 -0.744 . . . . 63.350000000000001 112.516 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 7' ' ' VAL . 5.9 p -49.36 121.5 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.846 0.355 . . . . 62.119999999999997 111.1 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 1.1 p -140.15 163.42 32.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 71.519999999999996 110.917 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -154.35 111.5 3.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 64.299999999999997 110.872 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.658 ' N ' HE21 ' A' ' 14' ' ' GLN . . . 145.95 156.59 6.94 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 73.040000000000006 112.514 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.3 pt -111.85 -30.08 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.742 0.306 . . . . 64.340000000000003 111.149 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.2 mm -72.28 -34.27 48.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 62.119999999999997 111.114 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -176.88 142.42 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 61.310000000000002 110.902 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.658 HE21 ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER 174.29 -58.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 75.239999999999995 110.853 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 6.4 m -92.36 -166.65 1.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 73.140000000000001 110.809 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -135.92 128.96 31.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 64.530000000000001 110.938 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.502 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -67.89 160.39 74.12 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.619 0.723 . . . . 62.100000000000001 110.813 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 52.7 Cg_endo -69.86 -8.95 10.96 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.725 -1.781 . . . . 71.239999999999995 112.312 0.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -71.22 162.65 29.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 72.219999999999999 110.953 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -174.49 145.6 0.97 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 70.239999999999995 110.909 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -45.23 147.23 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 75.409999999999997 110.897 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.646 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER 177.56 170.34 0.44 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.713 . . . . 64.329999999999998 110.884 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 1.009 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 54.0 Cg_endo -69.7 -32.57 3.83 Favored 'Cis proline' 0 C--O 1.231 0.161 0 C-N-CA 122.664 -1.807 . . . . 74.319999999999993 112.365 -0.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.009 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.7 Cg_endo -69.81 -162.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.697 2.264 . . . . 74.010000000000005 112.334 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 26' ' ' TYR . 1.4 tt -93.13 -40.98 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 73.129999999999995 111.171 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.424 ' N ' HG23 ' A' ' 25' ' ' ILE . 6.4 m-30 -109.56 79.22 1.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 74.310000000000002 110.93 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.61 -124.77 1.86 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.748 . . . . 61.119999999999997 112.488 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -121.14 147.21 45.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.372 . . . . 72.010000000000005 110.849 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.739 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 17.9 m -65.54 146.65 54.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 64.540000000000006 110.86 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.648 HD13 ' O ' ' A' ' 29' ' ' CYS . 45.5 mm . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 71.030000000000001 111.139 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.86 0.362 . . . . 72.25 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.605 HG13 ' HD2' ' A' ' 3' ' ' PRO . 95.9 t -91.06 136.87 26.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.555 0.693 . . . . 72.340000000000003 111.171 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.605 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.4 Cg_endo -69.78 -92.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.668 2.245 . . . . 75.140000000000001 112.381 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.483 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 1.8 tt0 -146.47 145.4 30.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 74.049999999999997 110.916 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 58.92 25.99 14.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.42 . . . . 72.040000000000006 110.898 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -100.67 29.2 12.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 72.420000000000002 112.432 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.518 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 p 35.49 82.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 65.019999999999996 111.155 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.2 p -103.05 170.5 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 72.329999999999998 110.844 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.404 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.82 114.51 3.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 43.32 110.886 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.36 161.3 10.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 73.019999999999996 112.512 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.562 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -105.36 -44.51 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 61.049999999999997 111.143 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.8 mm -84.1 -64.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 72.219999999999999 111.186 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -126.66 127.15 44.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.030000000000001 110.859 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -178.39 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 71.040000000000006 110.923 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.1 m -120.94 -165.98 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 62.25 110.886 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -136.57 137.74 40.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 61.329999999999998 110.932 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.532 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 3.1 p30 -60.15 155.23 46.53 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.556 0.694 . . . . 64.349999999999994 110.879 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.84 -11.77 12.15 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.594 -1.836 . . . . 61.43 112.35 0.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -65.56 169.19 6.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.334 -0.394 . . . . 71.310000000000002 110.893 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -172.62 33.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.506 . . . . 75.230000000000004 110.913 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER 65.45 135.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 65.040000000000006 110.871 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.628 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 174.75 171.7 0.27 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.678 0.752 . . . . 61.130000000000003 110.852 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 1.025 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.6 Cg_endo -69.78 -32.91 3.64 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.729 -1.779 . . . . 73.140000000000001 112.376 -0.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.025 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.7 Cg_endo -69.76 -161.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.662 2.241 . . . . 74.450000000000003 112.323 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.32 -36.62 6.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 53.229999999999997 111.108 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.404 ' CE2' ' HB2' ' A' ' 9' ' ' ASP . 3.2 m-85 -117.89 77.64 1.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.540000000000006 110.93 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.01 -119.18 1.4 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.755 . . . . 52.439999999999998 112.448 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -116.34 153.33 32.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.818 0.342 . . . . 70.310000000000002 110.805 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.721 ' O ' HD13 ' A' ' 30' ' ' ILE . 76.5 m -73.07 125.98 28.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 73.219999999999999 110.873 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.721 HD13 ' O ' ' A' ' 29' ' ' CYS . 11.3 mm . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 72.219999999999999 111.112 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.5 p . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.89 0.376 . . . . 40.219999999999999 110.944 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.607 HG13 ' HD2' ' A' ' 3' ' ' PRO . 68.0 t -105.69 137.51 19.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.628 0.728 . . . . 74.329999999999998 111.134 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.607 ' HD2' HG13 ' A' ' 2' ' ' VAL . 52.6 Cg_endo -69.79 -87.8 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.686 2.257 . . . . 72.209999999999994 112.297 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -150.09 151.01 32.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 64.409999999999997 110.913 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 64.74 24.98 12.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 75.530000000000001 110.941 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.73 114.91 3.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 62.310000000000002 112.51 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 7' ' ' VAL . 3.8 p -47.65 113.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 64.209999999999994 111.178 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 1.2 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 2.9 p -133.46 169.26 17.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 72.129999999999995 110.947 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -156.2 120.95 4.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.198 -0.455 . . . . 72.340000000000003 110.906 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' N ' HE21 ' A' ' 14' ' ' GLN . . . 154.12 175.65 25.59 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.77 -0.729 . . . . 52.119999999999997 112.493 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.567 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -115.1 -46.69 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.84 0.353 . . . . 64.200000000000003 111.133 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 13' ' ' ASN . 9.6 mm -84.43 -66.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 61.299999999999997 111.078 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.432 ' N ' HG22 ' A' ' 12' ' ' ILE . 8.6 p30 -114.17 135.37 54.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 62.530000000000001 110.846 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.457 HE21 ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER 179.67 -50.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 65.400000000000006 110.898 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 1.2 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 56.6 m -114.92 -162.54 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 71.349999999999994 110.898 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.6 OUTLIER -135.22 127.43 30.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 62.100000000000001 110.834 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.498 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -65.08 160.3 57.9 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.606 0.717 . . . . 75.099999999999994 110.885 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.0 Cg_endo -69.85 -9.55 11.25 Favored 'Cis proline' 0 C--O 1.232 0.177 0 C-N-CA 122.606 -1.831 . . . . 51.149999999999999 112.321 0.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -70.93 164.03 26.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 74.409999999999997 110.953 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -175.51 145.56 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 73.329999999999998 110.959 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -45.59 145.34 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 52.310000000000002 110.898 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.615 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER 179.98 169.78 0.66 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.677 0.751 . . . . 43.130000000000003 110.86 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 1.049 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.3 Cg_endo -69.78 -33.41 3.43 Favored 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.73 -1.779 . . . . 74.409999999999997 112.297 0.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.049 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.8 Cg_endo -69.78 -162.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.693 2.262 . . . . 50.0 112.341 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 tt -95.3 -34.73 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 71.239999999999995 111.144 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.8 m-30 -113.45 79.36 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 74.310000000000002 110.951 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.49 -124.18 1.56 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 72.319999999999993 112.517 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -121.47 148.43 44.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 65.120000000000005 110.83 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.73 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 16.5 m -66.45 147.04 53.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 75.400000000000006 110.931 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 29' ' ' CYS . 47.2 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 73.310000000000002 111.094 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.93 0.395 . . . . 75.230000000000004 110.824 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.583 HG13 ' HD2' ' A' ' 3' ' ' PRO . 97.5 t -98.14 136.34 21.03 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.661 0.743 . . . . 64.540000000000006 111.113 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.583 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.8 Cg_endo -69.83 -91.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.619 2.212 . . . . 54.109999999999999 112.372 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.449 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 3.3 tt0 -146.54 146.66 30.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.425 . . . . 74.219999999999999 110.91 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 57.5 43.42 22.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 65.150000000000006 110.849 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -120.57 28.36 6.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.74 . . . . 72.519999999999996 112.467 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.516 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 p 35.84 83.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.363 . . . . 53.530000000000001 111.102 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 p -102.75 169.86 8.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 51.329999999999998 110.923 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -155.01 119.47 4.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 71.340000000000003 110.872 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.99 175.29 28.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 73.420000000000002 112.492 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.7 tp -109.18 -43.4 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 64.019999999999996 111.164 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.1 mt -109.97 -57.78 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 74.230000000000004 111.134 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -106.16 122.83 47.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 75.239999999999995 110.873 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 176.76 -46.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 110.939 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 20' ' ' TYR . 69.7 m -113.06 -162.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 71.25 110.894 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.09 137.23 42.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 64.310000000000002 110.974 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.554 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 10.3 m-20 -59.21 150.79 61.28 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 64.150000000000006 110.793 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.554 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.68 -22.96 9.26 Favored 'Cis proline' 0 C--N 1.342 0.235 0 C-N-CA 122.678 -1.801 . . . . 75.019999999999996 112.348 -0.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -51.35 163.59 0.25 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 73.329999999999998 110.968 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.422 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -171.39 30.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.5 . . . . 72.450000000000003 110.894 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 64.59 143.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 61.439999999999998 110.866 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.616 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 173.75 171.81 0.25 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.694 0.759 . . . . 71.439999999999998 110.836 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 1.042 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.9 Cg_endo -69.76 -33.53 3.38 Favored 'Cis proline' 0 C--O 1.231 0.164 0 C-N-CA 122.684 -1.798 . . . . 43.32 112.322 0.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.042 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 54.3 Cg_endo -69.67 -162.11 0.09 OUTLIER 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.674 2.25 . . . . 64.540000000000006 112.382 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.1 -36.81 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 71.019999999999996 111.098 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.5 m-30 -115.76 79.3 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 73.230000000000004 110.874 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.22 -120.9 1.55 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.779 -0.724 . . . . 61.32 112.504 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 40.6 m-70 -117.4 150.39 38.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.863 0.363 . . . . 71.230000000000004 110.845 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.713 ' O ' HD13 ' A' ' 30' ' ' ILE . 70.9 m -70.14 126.74 30.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 74.450000000000003 110.924 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.713 HD13 ' O ' ' A' ' 29' ' ' CYS . 15.5 mm . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.13 -0.486 . . . . 73.549999999999997 111.122 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 1.283 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.953 0.406 . . . . 63.219999999999999 110.827 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.557 HG13 ' HD2' ' A' ' 3' ' ' PRO . 43.9 t -148.73 136.96 11.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.6 0.714 . . . . 53.420000000000002 111.125 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.557 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.4 Cg_endo -69.65 -91.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.716 2.277 . . . . 54.219999999999999 112.377 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.436 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 6.2 tt0 -145.38 147.45 32.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 71.099999999999994 110.932 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 57.01 44.68 22.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 74.239999999999995 110.916 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -113.72 23.51 13.2 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 73.129999999999995 112.447 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.483 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.3 p 35.62 85.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.83 0.348 . . . . 54.549999999999997 111.113 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.3 p -113.71 172.98 6.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 73.310000000000002 110.923 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -158.38 118.83 3.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 75.430000000000007 110.831 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.01 158.12 7.59 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.755 -0.736 . . . . 64.409999999999997 112.515 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.45 HG22 HG13 ' A' ' 25' ' ' ILE . 1.6 pp -109.64 -27.56 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 72.209999999999994 111.144 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.3 mt -89.33 -35.37 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 73.209999999999994 111.168 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -163.08 133.39 4.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 71.129999999999995 110.889 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.7 -31.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.474 . . . . 71.129999999999995 110.899 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.9 m -136.78 -166.73 1.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 73.510000000000005 110.926 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 1.283 ' SG ' ' SG ' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -130.46 149.57 52.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 110.919 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.531 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 1.7 p30 -66.52 156.31 86.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.65 0.738 . . . . 62.43 110.861 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.531 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.3 Cg_endo -69.78 -14.49 12.53 Favored 'Cis proline' 0 C--N 1.342 0.214 0 C-N-CA 122.694 -1.794 . . . . 71.239999999999995 112.375 0.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -63.74 170.19 3.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 74.299999999999997 110.915 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.78 35.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 74.219999999999999 110.878 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER 65.35 138.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 70.430000000000007 110.89 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.655 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 174.42 172.7 0.25 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.627 0.727 . . . . 72.299999999999997 110.867 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 1.002 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.8 Cg_endo -69.76 -32.29 4.02 Favored 'Cis proline' 0 C--N 1.341 0.176 0 C-N-CA 122.674 -1.803 . . . . 65.040000000000006 112.366 0.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.002 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.0 Cg_endo -69.82 -164.09 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.672 2.248 . . . . 71.430000000000007 112.359 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.45 HG13 HG22 ' A' ' 11' ' ' ILE . 4.0 tt -90.02 -38.89 11.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 74.439999999999998 111.181 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.405 ' N ' HG23 ' A' ' 25' ' ' ILE . 14.4 m-30 -119.05 87.71 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 74.349999999999994 110.9 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.73 -123.45 1.06 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.784 -0.722 . . . . 32.409999999999997 112.488 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.91 149.66 27.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 62.350000000000001 110.878 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.759 ' O ' HD13 ' A' ' 30' ' ' ILE . 85.9 m -72.05 120.29 17.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 43.509999999999998 110.795 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.759 HD13 ' O ' ' A' ' 29' ' ' CYS . 6.0 mm . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 74.420000000000002 111.088 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.851 0.358 . . . . 75.049999999999997 110.814 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.598 HG13 ' HD2' ' A' ' 3' ' ' PRO . 90.6 t -95.07 136.79 22.46 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.641 0.734 . . . . 72.430000000000007 111.18 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.598 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.7 Cg_endo -69.72 -92.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.712 2.275 . . . . 64.319999999999993 112.371 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 3.6 tt0 -146.4 146.74 30.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 54.149999999999999 110.889 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 58.48 41.28 22.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 74.239999999999995 110.943 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -117.56 27.99 7.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 61.009999999999998 112.46 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.518 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 p 35.7 82.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.946 0.403 . . . . 64.439999999999998 111.138 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.7 p -103.25 168.6 9.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 61.340000000000003 110.895 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.15 119.4 4.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 62.109999999999999 110.771 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.63 166.13 13.99 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.797 -0.716 . . . . 73.040000000000006 112.529 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.574 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -107.19 -44.44 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.728 0.299 . . . . 72.239999999999995 111.121 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 13' ' ' ASN . 9.6 mm -85.29 -65.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 53.049999999999997 111.112 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.424 ' N ' HG22 ' A' ' 12' ' ' ILE . 12.1 p30 -122.86 131.46 53.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 62.130000000000003 110.876 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.35 -25.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 64.530000000000001 110.966 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' HB2' ' HA ' ' A' ' 20' ' ' TYR . 58.6 m -133.13 -164.25 1.45 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 65.209999999999994 110.894 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.413 ' H ' ' HB3' ' A' ' 15' ' ' CYS . 0.6 OUTLIER -137.23 139.99 41.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.463 . . . . 64.349999999999994 110.853 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.536 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 4.7 p30 -61.35 154.84 61.18 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.648 0.737 . . . . 74.420000000000002 110.78 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.536 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 55.2 Cg_endo -69.61 -12.31 11.85 Favored 'Cis proline' 0 C--O 1.232 0.205 0 C-N-CA 122.703 -1.791 . . . . 51.299999999999997 112.385 -0.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -65.02 168.42 6.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 72.109999999999999 110.888 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.417 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -175.09 34.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 71.310000000000002 110.875 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER 64.82 139.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 61.240000000000002 110.899 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.612 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 172.4 171.15 0.22 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.623 0.725 . . . . 73.349999999999994 110.895 -179.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 1.052 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 54.0 Cg_endo -69.78 -33.47 3.41 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.621 -1.824 . . . . 73.450000000000003 112.379 0.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.052 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.7 Cg_endo -69.75 -161.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.655 2.237 . . . . 71.340000000000003 112.33 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -96.17 -37.44 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 54.210000000000001 111.103 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.4 m-30 -116.24 77.51 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 73.430000000000007 110.915 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.18 -119.74 1.51 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 51.439999999999998 112.488 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -116.72 153.32 32.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 73.450000000000003 110.81 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.727 ' O ' HD13 ' A' ' 30' ' ' ILE . 74.6 m -71.64 126.06 28.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 75.219999999999999 110.934 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.727 HD13 ' O ' ' A' ' 29' ' ' CYS . 10.2 mm . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 72.430000000000007 111.171 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.916 0.389 . . . . 62.109999999999999 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.598 HG13 ' HD2' ' A' ' 3' ' ' PRO . 97.8 t -99.14 136.69 20.45 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.628 0.728 . . . . 75.349999999999994 111.131 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.598 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.0 Cg_endo -69.8 -92.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.627 2.218 . . . . 73.129999999999995 112.31 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.49 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 3.3 tt0 -146.26 145.84 30.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 75.099999999999994 110.942 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 58.02 41.98 23.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 62.43 110.889 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -120.25 29.09 6.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.791 -0.719 . . . . 62.509999999999998 112.519 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.522 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 p 35.92 82.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.341 . . . . 74.120000000000005 111.14 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.4 p -101.64 169.34 8.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 41.119999999999997 110.917 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -156.35 119.21 4.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 73.099999999999994 110.883 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.26 166.14 17.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.7 -0.762 . . . . 24.41 112.473 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.558 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -112.31 -44.11 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.863 0.363 . . . . 73.349999999999994 111.109 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.3 mm -91.62 -63.7 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 74.450000000000003 111.142 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -120.61 134.23 55.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 73.019999999999996 110.882 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.88 -74.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 74.010000000000005 110.884 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.441 ' HB2' ' HA ' ' A' ' 20' ' ' TYR . 60.7 m -80.42 -163.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 65.409999999999997 110.912 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.81 138.45 42.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 65.209999999999994 110.916 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.549 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 24.1 m-20 -59.61 152.14 58.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.604 0.716 . . . . 74.209999999999994 110.912 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.549 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.68 -19.11 11.29 Favored 'Cis proline' 0 C--N 1.342 0.219 0 C-N-CA 122.62 -1.825 . . . . 60.329999999999998 112.392 -0.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -56.44 167.26 0.72 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.443 . . . . 75.140000000000001 110.875 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -172.48 31.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 74.120000000000005 110.927 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 64.36 141.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.096 -0.502 . . . . 54.119999999999997 110.918 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.618 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 173.72 171.63 0.25 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.727 0.775 . . . . 60.539999999999999 110.796 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 1.038 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.1 Cg_endo -69.82 -33.36 3.46 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.669 -1.804 . . . . 73.530000000000001 112.364 0.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.038 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.3 Cg_endo -69.73 -162.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.722 2.281 . . . . 73.439999999999998 112.293 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.3 -37.34 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.466 . . . . 71.019999999999996 111.149 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.5 m-30 -115.88 77.92 1.14 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 71.420000000000002 110.921 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.97 -120.52 1.61 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.727 -0.749 . . . . 60.539999999999999 112.496 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -117.35 151.42 37.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 73.109999999999999 110.849 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.724 ' O ' HD13 ' A' ' 30' ' ' ILE . 70.8 m -71.33 126.65 30.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 71.239999999999995 110.875 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 29' ' ' CYS . 12.7 mm . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 64.319999999999993 111.117 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.2 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.84 0.352 . . . . 63.009999999999998 110.874 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.552 HG13 ' HD2' ' A' ' 3' ' ' PRO . 86.8 t -95.44 135.73 23.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.58 0.705 . . . . 73.019999999999996 111.196 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.552 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.7 Cg_endo -69.76 -91.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.691 2.26 . . . . 73.400000000000006 112.353 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.448 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 6.6 tt0 -144.65 147.11 32.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 74.329999999999998 110.856 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 57.7 43.33 22.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 72.239999999999995 110.965 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -120.17 27.83 6.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 65.310000000000002 112.513 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.498 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.3 p 35.68 85.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.922 0.391 . . . . 75.299999999999997 111.17 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.7 p -105.98 172.93 6.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 71.530000000000001 110.857 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -161.37 120.05 2.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 75.409999999999997 110.834 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.68 157.72 8.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.681 -0.771 . . . . 24.140000000000001 112.494 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -114.7 -28.51 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.812 0.339 . . . . 74.420000000000002 111.152 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.0 mm -75.39 -34.91 31.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 74.319999999999993 111.157 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -175.18 135.25 0.34 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 52.130000000000003 110.889 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.455 ' NE2' ' H ' ' A' ' 15' ' ' CYS . 0.1 OUTLIER 176.54 -61.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 71.420000000000002 110.962 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.455 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 92.8 m -90.64 -165.64 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 74.439999999999998 110.841 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.56 137.35 40.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 75.200000000000003 110.874 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.546 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 5.3 m-20 -58.77 149.86 61.68 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.667 0.746 . . . . 71.239999999999995 110.854 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.546 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.73 -23.36 9.09 Favored 'Cis proline' 0 C--N 1.342 0.196 0 C-N-CA 122.714 -1.786 . . . . 71.019999999999996 112.284 -0.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -50.42 160.65 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 74.150000000000006 110.938 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.5 32.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 71.239999999999995 110.937 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 65.08 143.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 74.230000000000004 110.862 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.633 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 173.8 170.65 0.26 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.683 0.754 . . . . 60.100000000000001 110.829 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 1.03 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 54.2 Cg_endo -69.69 -33.02 3.55 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.748 -1.772 . . . . 61.25 112.364 -0.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.03 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.9 Cg_endo -69.81 -161.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.623 2.215 . . . . 71.450000000000003 112.402 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 tt -97.23 -35.81 5.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 75.209999999999994 111.117 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -116.19 76.74 1.04 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 71.219999999999999 110.919 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.77 -120.58 1.63 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 62.140000000000001 112.48 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 43.8 m-70 -116.9 149.76 39.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.331 . . . . 63.520000000000003 110.914 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.706 ' O ' HD13 ' A' ' 30' ' ' ILE . 77.1 m -68.71 128.18 35.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 62.219999999999999 110.842 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.706 HD13 ' O ' ' A' ' 29' ' ' CYS . 17.3 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.493 . . . . 72.109999999999999 111.154 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.934 0.397 . . . . 65.450000000000003 110.795 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 3' ' ' PRO . 96.4 t -90.98 136.87 27.01 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 75.409999999999997 111.138 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.0 Cg_endo -69.71 -91.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.693 2.262 . . . . 65.140000000000001 112.374 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -147.12 154.62 41.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 54.149999999999999 110.912 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 64.37 14.9 9.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 71.519999999999996 110.938 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.7 114.57 4.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 64.400000000000006 112.465 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 7' ' ' VAL . 2.7 p -43.36 105.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.839 0.352 . . . . 65.439999999999998 111.197 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.0 p -123.32 167.9 13.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 52.229999999999997 110.84 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.522 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -159.63 108.86 1.83 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.102 -0.499 . . . . 73.340000000000003 110.897 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.9 159.15 9.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.66 -0.781 . . . . 72.439999999999998 112.416 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.571 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -101.66 -43.54 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.774 0.321 . . . . 70.5 111.114 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 13' ' ' ASN . 7.6 mm -84.01 -62.92 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 71.510000000000005 111.142 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.414 ' N ' HG22 ' A' ' 12' ' ' ILE . 7.3 p-10 -123.79 123.67 40.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 71.540000000000006 110.945 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -177.88 -33.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 74.129999999999995 110.883 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.6 m -129.87 -162.15 1.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 73.120000000000005 110.974 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -135.83 135.84 40.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 71.129999999999995 110.946 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.535 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 90.2 m-20 -59.36 154.76 40.86 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.617 0.723 . . . . 63.409999999999997 110.8 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.535 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.8 -16.0 12.39 Favored 'Cis proline' 0 C--N 1.342 0.188 0 C-N-CA 122.679 -1.8 . . . . 73.519999999999996 112.368 0.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -59.01 169.05 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 73.519999999999996 110.921 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.26 38.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 74.030000000000001 110.966 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 64.17 147.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 63.219999999999999 110.853 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.713 ' CB ' ' HA ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER 174.75 175.65 0.22 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.617 0.723 . . . . 53.32 110.843 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.939 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.2 Cg_endo -69.82 -31.64 4.44 Favored 'Cis proline' 0 C--O 1.232 0.204 0 C-N-CA 122.675 -1.802 . . . . 53.409999999999997 112.327 -0.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.939 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.5 Cg_endo -69.76 -92.02 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.688 2.259 . . . . 64.319999999999993 112.346 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -168.81 -34.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 111.122 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.4 m-30 -109.93 66.51 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 64.109999999999999 110.962 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.64 -110.55 0.64 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.826 -0.702 . . . . 63.25 112.559 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -111.93 149.35 32.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 70.450000000000003 110.865 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.788 ' O ' HD13 ' A' ' 30' ' ' ILE . 90.8 m -72.97 120.8 19.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 73.030000000000001 110.889 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.788 HD13 ' O ' ' A' ' 29' ' ' CYS . 5.9 mm . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 73.340000000000003 111.097 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 1.302 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.89 0.376 . . . . 75.310000000000002 110.845 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.547 HG13 ' HD2' ' A' ' 3' ' ' PRO . 57.5 t -150.71 136.02 10.25 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 53.100000000000001 111.173 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.6 Cg_endo -69.68 -92.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.746 2.297 . . . . 44.439999999999998 112.406 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -148.38 149.54 31.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 64.25 110.881 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 59.48 25.97 14.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 75.519999999999996 110.911 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -100.1 22.34 40.6 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.68 -0.771 . . . . 70.230000000000004 112.564 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.493 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.3 p 35.92 85.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 44.310000000000002 111.102 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.6 p -109.51 169.06 8.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 62.340000000000003 110.875 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -153.34 117.77 4.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 72.329999999999998 110.838 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.32 156.75 7.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.709 -0.757 . . . . 64.230000000000004 112.425 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.546 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -98.64 -42.41 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 75.209999999999994 111.127 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 12' ' ' ILE . 7.8 mm -89.01 -62.84 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.310000000000002 111.211 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.402 ' N ' HG22 ' A' ' 12' ' ' ILE . 15.5 p-10 -120.1 127.58 52.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 74.430000000000007 110.84 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.25 -34.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 75.030000000000001 110.944 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.407 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 97.7 m -133.96 -167.06 1.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 71.120000000000005 110.899 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 1.302 ' SG ' ' SG ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -132.99 157.79 44.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 75.200000000000003 110.867 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.52 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -72.2 156.82 90.25 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.609 0.719 . . . . 64.519999999999996 110.863 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.7 -12.56 12.11 Favored 'Cis proline' 0 C--N 1.341 0.182 0 C-N-CA 122.718 -1.784 . . . . 64.010000000000005 112.343 -0.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -66.0 176.58 1.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 75.519999999999996 110.871 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.97 36.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 70.109999999999999 110.857 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 65.14 136.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.468 . . . . 74.040000000000006 110.872 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.655 ' CB ' ' HA ' ' A' ' 23' ' ' PRO . 0.5 OUTLIER 169.73 173.29 0.13 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.672 0.749 . . . . 71.120000000000005 110.846 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 1.036 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.0 Cg_endo -69.76 -33.14 3.52 Favored 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.715 -1.785 . . . . 62.130000000000003 112.337 -0.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.036 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 54.1 Cg_endo -69.74 -161.46 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.641 2.227 . . . . 53.520000000000003 112.435 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.07 -33.65 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.306 -0.406 . . . . 55.130000000000003 111.161 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.2 m-85 -122.42 68.44 0.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 72.319999999999993 110.922 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -138.81 -117.79 1.54 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.792 -0.718 . . . . 55.130000000000003 112.533 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.47 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 54.2 m-70 -104.2 -177.05 3.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 63.140000000000001 110.863 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.743 ' O ' HD13 ' A' ' 30' ' ' ILE . 98.4 m -107.66 121.48 44.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 73.319999999999993 110.897 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.743 HD13 ' O ' ' A' ' 29' ' ' CYS . 4.6 mm . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 73.150000000000006 111.088 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 23.4 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.862 0.363 . . . . 34.240000000000002 110.954 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.586 HG13 ' HD2' ' A' ' 3' ' ' PRO . 79.3 t -90.8 136.69 27.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.532 0.682 . . . . 61.299999999999997 111.166 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.586 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.5 Cg_endo -69.79 -88.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.63 2.22 . . . . 71.310000000000002 112.349 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -151.25 148.62 28.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 74.439999999999998 110.901 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 67.07 13.38 9.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 73.200000000000003 110.885 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.2 114.26 4.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 75.430000000000007 112.489 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 7' ' ' VAL . 2.7 p -45.89 104.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.898 0.38 . . . . 61.140000000000001 111.112 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 5.0 p -121.8 172.36 8.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 73.310000000000002 110.889 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.93 118.74 4.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 63.539999999999999 110.931 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.81 174.67 30.93 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 50.219999999999999 112.456 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.533 ' O ' HD12 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -109.43 -42.49 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.333 . . . . 71.319999999999993 111.108 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 65.2 mt -109.92 -57.79 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 72.209999999999994 111.122 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -107.52 119.27 38.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 72.129999999999995 110.944 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 179.87 -31.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 74.109999999999999 110.91 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 1.259 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 33.1 m -126.85 -164.02 1.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 73.140000000000001 110.901 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -135.63 131.11 35.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.455 . . . . 74.329999999999998 110.872 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.495 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -69.09 160.24 79.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.544 0.688 . . . . 72.140000000000001 110.882 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.4 Cg_endo -69.79 -9.84 11.26 Favored 'Cis proline' 0 C--O 1.232 0.213 0 C-N-CA 122.681 -1.8 . . . . 73.409999999999997 112.316 0.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.2 163.51 26.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.238 -0.437 . . . . 72.120000000000005 110.919 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -173.05 146.45 1.49 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 75.319999999999993 110.915 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -48.05 145.37 3.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 62.43 110.899 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.66 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 174.95 171.2 0.29 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.733 0.777 . . . . 54.109999999999999 110.877 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.988 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.9 Cg_endo -69.71 -32.13 4.1 Favored 'Cis proline' 0 C--N 1.342 0.214 0 C-N-CA 122.649 -1.813 . . . . 74.409999999999997 112.382 -0.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.988 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 54.4 Cg_endo -69.78 -163.03 0.1 OUTLIER 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.691 2.261 . . . . 73.209999999999994 112.346 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -93.21 -38.1 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 60.329999999999998 111.111 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.7 m-30 -115.02 82.93 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 74.299999999999997 110.9 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -147.9 -121.12 1.2 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.645 -0.788 . . . . 54.539999999999999 112.443 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -122.4 151.77 40.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 70.030000000000001 110.823 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.97 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 13.1 m -75.38 148.41 39.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 73.099999999999994 110.875 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.731 HD13 ' O ' ' A' ' 29' ' ' CYS . 38.4 mm . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 71.230000000000004 111.167 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.88 0.372 . . . . 74.099999999999994 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.596 HG13 ' HD2' ' A' ' 3' ' ' PRO . 85.1 t -102.33 137.11 19.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 75.129999999999995 111.178 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.596 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.5 Cg_endo -69.73 -87.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.718 2.279 . . . . 71.150000000000006 112.348 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -148.68 151.02 34.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 74.25 110.956 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 64.7 28.4 13.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 72.120000000000005 110.898 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.421 ' HA3' HG11 ' A' ' 2' ' ' VAL . . . -116.88 119.15 4.38 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.737 -0.744 . . . . 63.350000000000001 112.516 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 7' ' ' VAL . 5.9 p -49.36 121.5 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.846 0.355 . . . . 62.119999999999997 111.1 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 1.1 p -140.15 163.42 32.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.208 -0.451 . . . . 71.519999999999996 110.917 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -154.35 111.5 3.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 64.299999999999997 110.872 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.658 ' N ' HE21 ' A' ' 14' ' ' GLN . . . 145.95 156.59 6.94 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 73.040000000000006 112.514 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.3 pt -111.85 -30.08 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.742 0.306 . . . . 64.340000000000003 111.149 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.2 mm -72.28 -34.27 48.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 62.119999999999997 111.114 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -176.88 142.42 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 61.310000000000002 110.902 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.658 HE21 ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER 174.29 -58.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 75.239999999999995 110.853 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 6.4 m -92.36 -166.65 1.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 73.140000000000001 110.809 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -135.92 128.96 31.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 64.530000000000001 110.938 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.502 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -67.89 160.39 74.12 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.619 0.723 . . . . 62.100000000000001 110.813 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 52.7 Cg_endo -69.86 -8.95 10.96 Favored 'Cis proline' 0 C--N 1.342 0.189 0 C-N-CA 122.725 -1.781 . . . . 71.239999999999995 112.312 0.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -71.22 162.65 29.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 72.219999999999999 110.953 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -174.49 145.6 0.97 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 70.239999999999995 110.909 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -45.23 147.23 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 75.409999999999997 110.897 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.646 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER 177.56 170.34 0.44 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.713 . . . . 64.329999999999998 110.884 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 1.009 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 54.0 Cg_endo -69.7 -32.57 3.83 Favored 'Cis proline' 0 C--O 1.231 0.161 0 C-N-CA 122.664 -1.807 . . . . 74.319999999999993 112.365 -0.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.009 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.7 Cg_endo -69.81 -162.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.697 2.264 . . . . 74.010000000000005 112.334 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 26' ' ' TYR . 1.4 tt -93.13 -40.98 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 73.129999999999995 111.171 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.424 ' N ' HG23 ' A' ' 25' ' ' ILE . 6.4 m-30 -109.56 79.22 1.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 74.310000000000002 110.93 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.61 -124.77 1.86 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.748 . . . . 61.119999999999997 112.488 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -121.14 147.21 45.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.372 . . . . 72.010000000000005 110.849 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.739 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 17.9 m -65.54 146.65 54.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 64.540000000000006 110.86 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.648 HD13 ' O ' ' A' ' 29' ' ' CYS . 45.5 mm . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 71.030000000000001 111.139 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.86 0.362 . . . . 72.25 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.605 HG13 ' HD2' ' A' ' 3' ' ' PRO . 95.9 t -91.06 136.87 26.88 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.555 0.693 . . . . 72.340000000000003 111.171 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.605 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.4 Cg_endo -69.78 -92.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.668 2.245 . . . . 75.140000000000001 112.381 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.483 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 1.8 tt0 -146.47 145.4 30.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 74.049999999999997 110.916 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 58.92 25.99 14.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.42 . . . . 72.040000000000006 110.898 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -100.67 29.2 12.89 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 72.420000000000002 112.432 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.518 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 p 35.49 82.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 65.019999999999996 111.155 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.2 p -103.05 170.5 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 72.329999999999998 110.844 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.404 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.82 114.51 3.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 43.32 110.886 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.36 161.3 10.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 73.019999999999996 112.512 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.562 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -105.36 -44.51 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 61.049999999999997 111.143 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.8 mm -84.1 -64.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 72.219999999999999 111.186 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -126.66 127.15 44.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.030000000000001 110.859 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -178.39 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 71.040000000000006 110.923 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.1 m -120.94 -165.98 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 62.25 110.886 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -136.57 137.74 40.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 61.329999999999998 110.932 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.532 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 3.1 p30 -60.15 155.23 46.53 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.556 0.694 . . . . 64.349999999999994 110.879 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.84 -11.77 12.15 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.594 -1.836 . . . . 61.43 112.35 0.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -65.56 169.19 6.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.334 -0.394 . . . . 71.310000000000002 110.893 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -172.62 33.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.506 . . . . 75.230000000000004 110.913 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER 65.45 135.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 65.040000000000006 110.871 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.628 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 174.75 171.7 0.27 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.678 0.752 . . . . 61.130000000000003 110.852 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 1.025 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.6 Cg_endo -69.78 -32.91 3.64 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.729 -1.779 . . . . 73.140000000000001 112.376 -0.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.025 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.7 Cg_endo -69.76 -161.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.662 2.241 . . . . 74.450000000000003 112.323 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.32 -36.62 6.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 53.229999999999997 111.108 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.404 ' CE2' ' HB2' ' A' ' 9' ' ' ASP . 3.2 m-85 -117.89 77.64 1.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.540000000000006 110.93 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.01 -119.18 1.4 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.713 -0.755 . . . . 52.439999999999998 112.448 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -116.34 153.33 32.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.818 0.342 . . . . 70.310000000000002 110.805 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.721 ' O ' HD13 ' A' ' 30' ' ' ILE . 76.5 m -73.07 125.98 28.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 73.219999999999999 110.873 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.721 HD13 ' O ' ' A' ' 29' ' ' CYS . 11.3 mm . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 72.219999999999999 111.112 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.5 p . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.89 0.376 . . . . 40.219999999999999 110.944 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.607 HG13 ' HD2' ' A' ' 3' ' ' PRO . 68.0 t -105.69 137.51 19.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.628 0.728 . . . . 74.329999999999998 111.134 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.607 ' HD2' HG13 ' A' ' 2' ' ' VAL . 52.6 Cg_endo -69.79 -87.8 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.686 2.257 . . . . 72.209999999999994 112.297 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -150.09 151.01 32.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 64.409999999999997 110.913 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 64.74 24.98 12.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 75.530000000000001 110.941 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.73 114.91 3.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 62.310000000000002 112.51 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 7' ' ' VAL . 3.8 p -47.65 113.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 64.209999999999994 111.178 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 1.2 ' SG ' ' SG ' ' A' ' 15' ' ' CYS . 2.9 p -133.46 169.26 17.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 72.129999999999995 110.947 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -156.2 120.95 4.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.198 -0.455 . . . . 72.340000000000003 110.906 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' N ' HE21 ' A' ' 14' ' ' GLN . . . 154.12 175.65 25.59 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.77 -0.729 . . . . 52.119999999999997 112.493 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.567 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -115.1 -46.69 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.84 0.353 . . . . 64.200000000000003 111.133 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 13' ' ' ASN . 9.6 mm -84.43 -66.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 61.299999999999997 111.078 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.432 ' N ' HG22 ' A' ' 12' ' ' ILE . 8.6 p30 -114.17 135.37 54.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 62.530000000000001 110.846 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.457 HE21 ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER 179.67 -50.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 65.400000000000006 110.898 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 1.2 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 56.6 m -114.92 -162.54 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 71.349999999999994 110.898 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.6 OUTLIER -135.22 127.43 30.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 62.100000000000001 110.834 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.498 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -65.08 160.3 57.9 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.606 0.717 . . . . 75.099999999999994 110.885 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.0 Cg_endo -69.85 -9.55 11.25 Favored 'Cis proline' 0 C--O 1.232 0.177 0 C-N-CA 122.606 -1.831 . . . . 51.149999999999999 112.321 0.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -70.93 164.03 26.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 74.409999999999997 110.953 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -175.51 145.56 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 73.329999999999998 110.959 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -45.59 145.34 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.156 -0.474 . . . . 52.310000000000002 110.898 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.615 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER 179.98 169.78 0.66 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.677 0.751 . . . . 43.130000000000003 110.86 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 1.049 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.3 Cg_endo -69.78 -33.41 3.43 Favored 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.73 -1.779 . . . . 74.409999999999997 112.297 0.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.049 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.8 Cg_endo -69.78 -162.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.693 2.262 . . . . 50.0 112.341 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 tt -95.3 -34.73 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 71.239999999999995 111.144 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.8 m-30 -113.45 79.36 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 74.310000000000002 110.951 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.49 -124.18 1.56 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.755 -0.736 . . . . 72.319999999999993 112.517 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -121.47 148.43 44.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 65.120000000000005 110.83 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.73 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 16.5 m -66.45 147.04 53.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 75.400000000000006 110.931 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.645 HD13 ' O ' ' A' ' 29' ' ' CYS . 47.2 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 73.310000000000002 111.094 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.93 0.395 . . . . 75.230000000000004 110.824 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.583 HG13 ' HD2' ' A' ' 3' ' ' PRO . 97.5 t -98.14 136.34 21.03 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.661 0.743 . . . . 64.540000000000006 111.113 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.583 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.8 Cg_endo -69.83 -91.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.619 2.212 . . . . 54.109999999999999 112.372 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.449 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 3.3 tt0 -146.54 146.66 30.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.425 . . . . 74.219999999999999 110.91 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 57.5 43.42 22.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 65.150000000000006 110.849 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -120.57 28.36 6.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.74 . . . . 72.519999999999996 112.467 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.516 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 p 35.84 83.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.363 . . . . 53.530000000000001 111.102 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 p -102.75 169.86 8.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 51.329999999999998 110.923 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -155.01 119.47 4.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 71.340000000000003 110.872 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.99 175.29 28.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 73.420000000000002 112.492 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.7 tp -109.18 -43.4 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.847 0.356 . . . . 64.019999999999996 111.164 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.1 mt -109.97 -57.78 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 74.230000000000004 111.134 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -106.16 122.83 47.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 75.239999999999995 110.873 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 176.76 -46.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 110.939 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 20' ' ' TYR . 69.7 m -113.06 -162.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 71.25 110.894 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.09 137.23 42.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 64.310000000000002 110.974 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.554 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 10.3 m-20 -59.21 150.79 61.28 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 64.150000000000006 110.793 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.554 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.68 -22.96 9.26 Favored 'Cis proline' 0 C--N 1.342 0.235 0 C-N-CA 122.678 -1.801 . . . . 75.019999999999996 112.348 -0.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -51.35 163.59 0.25 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 73.329999999999998 110.968 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.422 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -171.39 30.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.5 . . . . 72.450000000000003 110.894 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 64.59 143.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 61.439999999999998 110.866 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.616 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 173.75 171.81 0.25 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.694 0.759 . . . . 71.439999999999998 110.836 -179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 1.042 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.9 Cg_endo -69.76 -33.53 3.38 Favored 'Cis proline' 0 C--O 1.231 0.164 0 C-N-CA 122.684 -1.798 . . . . 43.32 112.322 0.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.042 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 54.3 Cg_endo -69.67 -162.11 0.09 OUTLIER 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.674 2.25 . . . . 64.540000000000006 112.382 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.1 -36.81 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 71.019999999999996 111.098 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.5 m-30 -115.76 79.3 1.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 73.230000000000004 110.874 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.22 -120.9 1.55 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.779 -0.724 . . . . 61.32 112.504 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 40.6 m-70 -117.4 150.39 38.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.863 0.363 . . . . 71.230000000000004 110.845 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.713 ' O ' HD13 ' A' ' 30' ' ' ILE . 70.9 m -70.14 126.74 30.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 74.450000000000003 110.924 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.713 HD13 ' O ' ' A' ' 29' ' ' CYS . 15.5 mm . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.13 -0.486 . . . . 73.549999999999997 111.122 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 1.283 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.953 0.406 . . . . 63.219999999999999 110.827 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.557 HG13 ' HD2' ' A' ' 3' ' ' PRO . 43.9 t -148.73 136.96 11.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.6 0.714 . . . . 53.420000000000002 111.125 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.557 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.4 Cg_endo -69.65 -91.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.716 2.277 . . . . 54.219999999999999 112.377 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.436 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 6.2 tt0 -145.38 147.45 32.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 71.099999999999994 110.932 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 57.01 44.68 22.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 74.239999999999995 110.916 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -113.72 23.51 13.2 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 73.129999999999995 112.447 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.483 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.3 p 35.62 85.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.83 0.348 . . . . 54.549999999999997 111.113 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.3 p -113.71 172.98 6.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 73.310000000000002 110.923 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -158.38 118.83 3.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 75.430000000000007 110.831 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.01 158.12 7.59 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.755 -0.736 . . . . 64.409999999999997 112.515 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.45 HG22 HG13 ' A' ' 25' ' ' ILE . 1.6 pp -109.64 -27.56 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.786 0.327 . . . . 72.209999999999994 111.144 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.3 mt -89.33 -35.37 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 73.209999999999994 111.168 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -163.08 133.39 4.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 71.129999999999995 110.889 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.7 -31.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.474 . . . . 71.129999999999995 110.899 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.9 m -136.78 -166.73 1.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 73.510000000000005 110.926 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 1.283 ' SG ' ' SG ' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -130.46 149.57 52.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 110.919 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.531 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 1.7 p30 -66.52 156.31 86.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.65 0.738 . . . . 62.43 110.861 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.531 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.3 Cg_endo -69.78 -14.49 12.53 Favored 'Cis proline' 0 C--N 1.342 0.214 0 C-N-CA 122.694 -1.794 . . . . 71.239999999999995 112.375 0.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -63.74 170.19 3.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 74.299999999999997 110.915 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.78 35.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 74.219999999999999 110.878 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER 65.35 138.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 70.430000000000007 110.89 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.655 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER 174.42 172.7 0.25 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.627 0.727 . . . . 72.299999999999997 110.867 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 1.002 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.8 Cg_endo -69.76 -32.29 4.02 Favored 'Cis proline' 0 C--N 1.341 0.176 0 C-N-CA 122.674 -1.803 . . . . 65.040000000000006 112.366 0.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.002 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.0 Cg_endo -69.82 -164.09 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.672 2.248 . . . . 71.430000000000007 112.359 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.45 HG13 HG22 ' A' ' 11' ' ' ILE . 4.0 tt -90.02 -38.89 11.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 74.439999999999998 111.181 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.405 ' N ' HG23 ' A' ' 25' ' ' ILE . 14.4 m-30 -119.05 87.71 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 74.349999999999994 110.9 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.73 -123.45 1.06 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.784 -0.722 . . . . 32.409999999999997 112.488 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.91 149.66 27.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 62.350000000000001 110.878 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.759 ' O ' HD13 ' A' ' 30' ' ' ILE . 85.9 m -72.05 120.29 17.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 43.509999999999998 110.795 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.759 HD13 ' O ' ' A' ' 29' ' ' CYS . 6.0 mm . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 74.420000000000002 111.088 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.851 0.358 . . . . 75.049999999999997 110.814 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.598 HG13 ' HD2' ' A' ' 3' ' ' PRO . 90.6 t -95.07 136.79 22.46 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.641 0.734 . . . . 72.430000000000007 111.18 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.598 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.7 Cg_endo -69.72 -92.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.712 2.275 . . . . 64.319999999999993 112.371 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 3.6 tt0 -146.4 146.74 30.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 54.149999999999999 110.889 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 58.48 41.28 22.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 74.239999999999995 110.943 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -117.56 27.99 7.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 61.009999999999998 112.46 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.518 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 p 35.7 82.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.946 0.403 . . . . 64.439999999999998 111.138 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.7 p -103.25 168.6 9.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 61.340000000000003 110.895 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -155.15 119.4 4.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 62.109999999999999 110.771 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.63 166.13 13.99 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.797 -0.716 . . . . 73.040000000000006 112.529 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.574 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -107.19 -44.44 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.728 0.299 . . . . 72.239999999999995 111.121 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 13' ' ' ASN . 9.6 mm -85.29 -65.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 53.049999999999997 111.112 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.424 ' N ' HG22 ' A' ' 12' ' ' ILE . 12.1 p30 -122.86 131.46 53.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 62.130000000000003 110.876 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.35 -25.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 64.530000000000001 110.966 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' HB2' ' HA ' ' A' ' 20' ' ' TYR . 58.6 m -133.13 -164.25 1.45 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 65.209999999999994 110.894 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.413 ' H ' ' HB3' ' A' ' 15' ' ' CYS . 0.6 OUTLIER -137.23 139.99 41.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.463 . . . . 64.349999999999994 110.853 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.536 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 4.7 p30 -61.35 154.84 61.18 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.648 0.737 . . . . 74.420000000000002 110.78 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.536 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 55.2 Cg_endo -69.61 -12.31 11.85 Favored 'Cis proline' 0 C--O 1.232 0.205 0 C-N-CA 122.703 -1.791 . . . . 51.299999999999997 112.385 -0.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -65.02 168.42 6.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 72.109999999999999 110.888 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.417 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -175.09 34.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 71.310000000000002 110.875 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER 64.82 139.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 61.240000000000002 110.899 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.612 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 172.4 171.15 0.22 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.623 0.725 . . . . 73.349999999999994 110.895 -179.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 1.052 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 54.0 Cg_endo -69.78 -33.47 3.41 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.621 -1.824 . . . . 73.450000000000003 112.379 0.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.052 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.7 Cg_endo -69.75 -161.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.655 2.237 . . . . 71.340000000000003 112.33 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -96.17 -37.44 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 54.210000000000001 111.103 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.4 m-30 -116.24 77.51 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 73.430000000000007 110.915 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -142.18 -119.74 1.51 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 51.439999999999998 112.488 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -116.72 153.32 32.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 73.450000000000003 110.81 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.727 ' O ' HD13 ' A' ' 30' ' ' ILE . 74.6 m -71.64 126.06 28.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 75.219999999999999 110.934 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.727 HD13 ' O ' ' A' ' 29' ' ' CYS . 10.2 mm . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 72.430000000000007 111.171 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.916 0.389 . . . . 62.109999999999999 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.598 HG13 ' HD2' ' A' ' 3' ' ' PRO . 97.8 t -99.14 136.69 20.45 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.628 0.728 . . . . 75.349999999999994 111.131 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.598 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.0 Cg_endo -69.8 -92.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.627 2.218 . . . . 73.129999999999995 112.31 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.49 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 3.3 tt0 -146.26 145.84 30.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 75.099999999999994 110.942 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 58.02 41.98 23.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 62.43 110.889 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -120.25 29.09 6.07 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.791 -0.719 . . . . 62.509999999999998 112.519 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.522 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.4 p 35.92 82.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.341 . . . . 74.120000000000005 111.14 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.4 p -101.64 169.34 8.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.275 -0.42 . . . . 41.119999999999997 110.917 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -156.35 119.21 4.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 73.099999999999994 110.883 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.26 166.14 17.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.7 -0.762 . . . . 24.41 112.473 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.558 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -112.31 -44.11 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.863 0.363 . . . . 73.349999999999994 111.109 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.3 mm -91.62 -63.7 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 74.450000000000003 111.142 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -120.61 134.23 55.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 73.019999999999996 110.882 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.88 -74.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 74.010000000000005 110.884 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.441 ' HB2' ' HA ' ' A' ' 20' ' ' TYR . 60.7 m -80.42 -163.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 65.409999999999997 110.912 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.81 138.45 42.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 65.209999999999994 110.916 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.549 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 24.1 m-20 -59.61 152.14 58.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.604 0.716 . . . . 74.209999999999994 110.912 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.549 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.68 -19.11 11.29 Favored 'Cis proline' 0 C--N 1.342 0.219 0 C-N-CA 122.62 -1.825 . . . . 60.329999999999998 112.392 -0.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -56.44 167.26 0.72 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.443 . . . . 75.140000000000001 110.875 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -172.48 31.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 74.120000000000005 110.927 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 64.36 141.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.096 -0.502 . . . . 54.119999999999997 110.918 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.618 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 173.72 171.63 0.25 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.727 0.775 . . . . 60.539999999999999 110.796 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 1.038 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.1 Cg_endo -69.82 -33.36 3.46 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.669 -1.804 . . . . 73.530000000000001 112.364 0.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.038 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.3 Cg_endo -69.73 -162.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.722 2.281 . . . . 73.439999999999998 112.293 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.3 -37.34 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.466 . . . . 71.019999999999996 111.149 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.5 m-30 -115.88 77.92 1.14 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 71.420000000000002 110.921 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.97 -120.52 1.61 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.727 -0.749 . . . . 60.539999999999999 112.496 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -117.35 151.42 37.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 73.109999999999999 110.849 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.724 ' O ' HD13 ' A' ' 30' ' ' ILE . 70.8 m -71.33 126.65 30.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 71.239999999999995 110.875 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 29' ' ' CYS . 12.7 mm . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 64.319999999999993 111.117 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.2 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.84 0.352 . . . . 63.009999999999998 110.874 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.552 HG13 ' HD2' ' A' ' 3' ' ' PRO . 86.8 t -95.44 135.73 23.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.58 0.705 . . . . 73.019999999999996 111.196 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.552 ' HD2' HG13 ' A' ' 2' ' ' VAL . 53.7 Cg_endo -69.76 -91.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.691 2.26 . . . . 73.400000000000006 112.353 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.448 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 6.6 tt0 -144.65 147.11 32.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 74.329999999999998 110.856 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 57.7 43.33 22.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 72.239999999999995 110.965 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -120.17 27.83 6.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 65.310000000000002 112.513 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.498 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.3 p 35.68 85.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.922 0.391 . . . . 75.299999999999997 111.17 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.7 p -105.98 172.93 6.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 71.530000000000001 110.857 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -161.37 120.05 2.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 75.409999999999997 110.834 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.68 157.72 8.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.681 -0.771 . . . . 24.140000000000001 112.494 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -114.7 -28.51 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.812 0.339 . . . . 74.420000000000002 111.152 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.0 mm -75.39 -34.91 31.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 74.319999999999993 111.157 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -175.18 135.25 0.34 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 52.130000000000003 110.889 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.455 ' NE2' ' H ' ' A' ' 15' ' ' CYS . 0.1 OUTLIER 176.54 -61.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 71.420000000000002 110.962 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.455 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 92.8 m -90.64 -165.64 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 74.439999999999998 110.841 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.56 137.35 40.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 75.200000000000003 110.874 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.546 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 5.3 m-20 -58.77 149.86 61.68 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.667 0.746 . . . . 71.239999999999995 110.854 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.546 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.73 -23.36 9.09 Favored 'Cis proline' 0 C--N 1.342 0.196 0 C-N-CA 122.714 -1.786 . . . . 71.019999999999996 112.284 -0.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -50.42 160.65 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 74.150000000000006 110.938 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.5 32.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 71.239999999999995 110.937 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 65.08 143.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 74.230000000000004 110.862 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.633 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 0.5 OUTLIER 173.8 170.65 0.26 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.683 0.754 . . . . 60.100000000000001 110.829 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 1.03 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 54.2 Cg_endo -69.69 -33.02 3.55 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.748 -1.772 . . . . 61.25 112.364 -0.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.03 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.9 Cg_endo -69.81 -161.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.623 2.215 . . . . 71.450000000000003 112.402 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 tt -97.23 -35.81 5.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 75.209999999999994 111.117 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -116.19 76.74 1.04 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 71.219999999999999 110.919 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.77 -120.58 1.63 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 62.140000000000001 112.48 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 43.8 m-70 -116.9 149.76 39.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.331 . . . . 63.520000000000003 110.914 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.706 ' O ' HD13 ' A' ' 30' ' ' ILE . 77.1 m -68.71 128.18 35.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 62.219999999999999 110.842 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.706 HD13 ' O ' ' A' ' 29' ' ' CYS . 17.3 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.493 . . . . 72.109999999999999 111.154 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 20.1 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.934 0.397 . . . . 65.450000000000003 110.795 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.608 HG13 ' HD2' ' A' ' 3' ' ' PRO . 96.4 t -90.98 136.87 27.01 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 75.409999999999997 111.138 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.0 Cg_endo -69.71 -91.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.693 2.262 . . . . 65.140000000000001 112.374 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -147.12 154.62 41.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 54.149999999999999 110.912 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 64.37 14.9 9.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 71.519999999999996 110.938 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.7 114.57 4.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.728 -0.749 . . . . 64.400000000000006 112.465 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 7' ' ' VAL . 2.7 p -43.36 105.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.839 0.352 . . . . 65.439999999999998 111.197 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.0 p -123.32 167.9 13.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 52.229999999999997 110.84 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.522 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -159.63 108.86 1.83 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.102 -0.499 . . . . 73.340000000000003 110.897 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.9 159.15 9.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.66 -0.781 . . . . 72.439999999999998 112.416 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.571 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -101.66 -43.54 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.774 0.321 . . . . 70.5 111.114 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 13' ' ' ASN . 7.6 mm -84.01 -62.92 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 71.510000000000005 111.142 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.414 ' N ' HG22 ' A' ' 12' ' ' ILE . 7.3 p-10 -123.79 123.67 40.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 71.540000000000006 110.945 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -177.88 -33.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 74.129999999999995 110.883 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.6 m -129.87 -162.15 1.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 73.120000000000005 110.974 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -135.83 135.84 40.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 71.129999999999995 110.946 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.535 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 90.2 m-20 -59.36 154.76 40.86 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.617 0.723 . . . . 63.409999999999997 110.8 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.535 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.8 -16.0 12.39 Favored 'Cis proline' 0 C--N 1.342 0.188 0 C-N-CA 122.679 -1.8 . . . . 73.519999999999996 112.368 0.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -59.01 169.05 1.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 73.519999999999996 110.921 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.26 38.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 74.030000000000001 110.966 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 64.17 147.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 63.219999999999999 110.853 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.713 ' CB ' ' HA ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER 174.75 175.65 0.22 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.617 0.723 . . . . 53.32 110.843 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.939 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.2 Cg_endo -69.82 -31.64 4.44 Favored 'Cis proline' 0 C--O 1.232 0.204 0 C-N-CA 122.675 -1.802 . . . . 53.409999999999997 112.327 -0.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.939 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 53.5 Cg_endo -69.76 -92.02 0.01 OUTLIER 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.688 2.259 . . . . 64.319999999999993 112.346 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -168.81 -34.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 111.122 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.4 m-30 -109.93 66.51 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 64.109999999999999 110.962 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.64 -110.55 0.64 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.826 -0.702 . . . . 63.25 112.559 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -111.93 149.35 32.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 70.450000000000003 110.865 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.788 ' O ' HD13 ' A' ' 30' ' ' ILE . 90.8 m -72.97 120.8 19.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 73.030000000000001 110.889 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.788 HD13 ' O ' ' A' ' 29' ' ' CYS . 5.9 mm . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 73.340000000000003 111.097 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 1.302 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.89 0.376 . . . . 75.310000000000002 110.845 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.547 HG13 ' HD2' ' A' ' 3' ' ' PRO . 57.5 t -150.71 136.02 10.25 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.627 0.727 . . . . 53.100000000000001 111.173 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HD2' HG13 ' A' ' 2' ' ' VAL . 54.6 Cg_endo -69.68 -92.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.746 2.297 . . . . 44.439999999999998 112.406 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -148.38 149.54 31.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 64.25 110.881 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 59.48 25.97 14.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.463 . . . . 75.519999999999996 110.911 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 7' ' ' VAL . . . -100.1 22.34 40.6 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.68 -0.771 . . . . 70.230000000000004 112.564 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.493 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.3 p 35.92 85.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 44.310000000000002 111.102 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.6 p -109.51 169.06 8.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 62.340000000000003 110.875 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -153.34 117.77 4.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 72.329999999999998 110.838 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.32 156.75 7.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.709 -0.757 . . . . 64.230000000000004 112.425 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.546 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -98.64 -42.41 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 75.209999999999994 111.127 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 12' ' ' ILE . 7.8 mm -89.01 -62.84 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.310000000000002 111.211 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.402 ' N ' HG22 ' A' ' 12' ' ' ILE . 15.5 p-10 -120.1 127.58 52.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 74.430000000000007 110.84 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.25 -34.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 75.030000000000001 110.944 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.407 ' HA ' ' HB ' ' A' ' 2' ' ' VAL . 97.7 m -133.96 -167.06 1.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 71.120000000000005 110.899 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 1.302 ' SG ' ' SG ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -132.99 157.79 44.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 75.200000000000003 110.867 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.52 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -72.2 156.82 90.25 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.609 0.719 . . . . 64.519999999999996 110.863 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.7 -12.56 12.11 Favored 'Cis proline' 0 C--N 1.341 0.182 0 C-N-CA 122.718 -1.784 . . . . 64.010000000000005 112.343 -0.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -66.0 176.58 1.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 75.519999999999996 110.871 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.97 36.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 70.109999999999999 110.857 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER 65.14 136.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.468 . . . . 74.040000000000006 110.872 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.655 ' CB ' ' HA ' ' A' ' 23' ' ' PRO . 0.5 OUTLIER 169.73 173.29 0.13 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.672 0.749 . . . . 71.120000000000005 110.846 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 1.036 ' HG2' ' HD3' ' A' ' 24' ' ' PRO . 53.0 Cg_endo -69.76 -33.14 3.52 Favored 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.715 -1.785 . . . . 62.130000000000003 112.337 -0.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.036 ' HD3' ' HG2' ' A' ' 23' ' ' PRO . 54.1 Cg_endo -69.74 -161.46 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.641 2.227 . . . . 53.520000000000003 112.435 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.07 -33.65 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.306 -0.406 . . . . 55.130000000000003 111.161 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 9' ' ' ASP . 3.2 m-85 -122.42 68.44 0.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 72.319999999999993 110.922 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -138.81 -117.79 1.54 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.792 -0.718 . . . . 55.130000000000003 112.533 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.47 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 54.2 m-70 -104.2 -177.05 3.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.846 0.355 . . . . 63.140000000000001 110.863 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.743 ' O ' HD13 ' A' ' 30' ' ' ILE . 98.4 m -107.66 121.48 44.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 73.319999999999993 110.897 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.743 HD13 ' O ' ' A' ' 29' ' ' CYS . 4.6 mm . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 73.150000000000006 111.088 179.942 . . . . . . . . 1 1 . 1 stop_ save_